Who is Who

  • Principal Investigator
  • Male

Prof. dr. F.C.H. Amant MD PhD

Position:
Main activities: Patient care, Research, Teaching
Specialisation:
foto F.C.H. Amant is one of the AMC Principal Investigators
Focus of research:
AMC themes: Oncology
Departments: Obstetrics and Gynaecology
Amant F, Trum H, Sentinel-lymph-node mapping in endometrial cancer: routine practice?. LANCET ONCOL 2017;18 (3):281-282 [PubMed]
Billiet T, Emsell L, Vandenbulcke M, Peeters R, Christiaens D, Leemans A, van Hecke W, Smeets A, Amant F, Sunaert S, Deprez S, Recovery from chemotherapy-induced white matter changes in young breast cancer survivors?. BRAIN IMAGING BEHAV 2017;ahead of print [PubMed]
Byrne AT, Alférez DG, Amant F, Annibali D, Arribas J, Biankin AV, Bruna A, Budinská E, Caldas C, Chang DK, Clarke RB, Clevers H, Coukos G, Dangles-Marie V, Eckhardt SG, Gonzalez-Suarez E, Hermans E, Hidalgo M, Jarzabek MA, de Jong S, Jonkers J, Kemper K, Lanfrancone L, Mælandsmo GM, Marangoni E, Marine JC, Medico E, Norum JH, Palmer HG, Peeper DS, Pelicci PG, Piris-Gimenez A, Roman-Roman S, Rueda OM, Seoane J, Serra V, Soucek L, Vanhecke D, Villanueva A, Vinolo E, Bertotti A, Trusolino L, Interrogating open issues in cancer precision medicine with patient-derived xenografts. NAT REV CANCER 2017;17 (4):254-268 [PubMed]
Cuppens T, Annibali D, Coosemans A, Trovik J, ter Haar N, Colas E, Garcia-Jimenez A, van de Vijver K, Kruitwagen RPM, Brinkhuis M, Zikan M, Dundr P, Huvila J, Carpén O, Haybaeck J, Moinfar F, Salvesen HB, Stukan M, Mestdagh C, Zweemer RP, Massuger LF, Mallmann MR, Wardelmann E, Mints M, Verbist G, Thomas D, Gommé E, Hermans E, Moerman P, Bosse T, Amant F, Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative. CLIN CANCER RES 2017;23 (5):1274-1285 [PubMed]
de Smet F, Saiz Rubio M, Hompes D, Naus E, de Baets G, Langenberg T, Hipp MS, Houben B, Claes F, Charbonneau S, Delgado Blanco J, Plaisance S, Ramkissoon S, Ramkissoon L, Simons C, van den Brandt P, Weijenberg M, van England M, Lambrechts S, Amant F, D'Hoore A, Ligon KL, Sagaert X, Schymkowitz J, Rousseau F, Nuclear inclusion bodies of mutant and wild-type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregation. J PATHOL 2017;242 (1):24-38 [PubMed]
Hveem TS, Njølstad TS, Nielsen B, Syvertsen RA, Nesheim JA, Kjæreng ML, Kildal W, Pradhan M, Marcickiewicz J, Tingulstad S, Staff AC, Haugland HK, Eraker R, Oddenes K, Rokne JA, Tjugum J, Lode MS, Amant F, Werner HMJ, Bjørge L, Albregtsen F, Liestøl K, Salvesen HB, Trovik J, Danielsen HE, Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial Cancer. CANCER EPIDEM BIOMAR 2017;26 (1):61-67 [PubMed]
Vandenbroucke T, Han SN, van Calsteren K, Wilderjans TF, van den Bergh BRH, Claes L, Amant F, Psychological distress and cognitive coping in pregnant women diagnosed with cancer and their partners. PSYCHO-ONCOLOGY 2017;26 (8):1215-1221 [PubMed]
Vanderstichele A, Busschaert P, Smeets D, Landolfo C, van Nieuwenhuysen E, Leunen K, Neven P, Amant F, Mahner S, Braicu EI, Zeilinger R, Coosemans A, Timmerman D, Lambrechts D, Vergote I, Chromosomal Instability in Cell-Free DNA as a Highly Specific Biomarker for Detection of Ovarian Cancer in Women with Adnexal Masses. CLIN CANCER RES 2017;23 (9):2223-2231 [PubMed]
Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, van den Berg DJ, Stram DO, Pearce CL, Wu AH, Brewster W, Anton-Culver H, Ziogas A, Narod SA, Levine DA, Kaye SB, Brown R, Paul J, Flanagan J, Sieh W, McGuire V, Whittemore AS, Campbell I, Gore ME, Lissowska J, Yang HP, Medrek K, Gronwald J, Lubinski J, Jakubowska A, Le ND, Cook LS, Kelemen LE, Brooks-Wilson A, Massuger LFAG, Kiemeney LA, Aben KKH, van Altena AM, Houlston R, Tomlinson I, Palmieri RT, Moorman PG, Schildkraut J, Iversen ES, Phelan C, Vierkant RA, Cunningham JM, Goode EL, Fridley BL, Kruger-Kjaer S, Blaeker J, Hogdall E, Hogdall C, Gross J, Karlan BY, Ness RB, Edwards RP, Odunsi K, Moyisch KB, Baker JA, Modugno F, Heikkinenen T, Butzow R, Nevanlinna H, Leminen A, Bogdanova N, Antonenkova N, Doerk T, Hillemanns P, Dürst M, Runnebaum I, Thompson PJ, Carney ME, Goodman MT, Lurie G, Wang-Gohrke S, Hein R, Chang-Claude J, Rossing MA, Cushing-Haugen KL, Doherty J, Chen C, Rafnar T, Besenbacher S, Sulem P, Stefansson K, Birrer MJ, Terry KL, Hernandez D, Cramer DW, Vergote I, Amant F, Lambrechts D, Despierre E, Fasching PA, Beckmann MW, Thiel FC, Ekici AB, Chen X, Johnatty SE, Webb PM, Beesley J, Chanock S, Garcia-Closas M, Sellers T, Easton DF, Berchuck A, Chenevix-Trench G, Pharoah PDP, Gayther SA, Common variants at 19p13 are associated with susceptibility to ovarian cancer (vol 42, pg 880, 2010). NAT GENET 2016;48 (1):101 [PubMed]
Cheng THT, Thompson DJ, O'Mara TA, Painter JN, Glubb DM, Flach S, Lewis A, French JD, Freeman-Mills L, Church D, Gorman M, Martin L, Hodgson S, Webb PM, Attia J, Holliday EG, McEvoy M, Scott RJ, Henders AK, Martin NG, Montgomery GW, Nyholt DR, Ahmed S, Healey CS, Shah M, Dennis J, Fasching PA, Beckmann MW, Hein A, Ekici AB, Hall P, Czene K, Darabi H, Li J, Dörk T, Dürst M, Hillemanns P, Runnebaum I, Amant F, Schrauwen S, Zhao H, Lambrechts D, Depreeuw J, Dowdy SC, Goode EL, Fridley BL, Winham SJ, Njølstad TS, Salvesen HB, Trovik J, Werner HMJ, Ashton K, Otton G, Proietto T, Liu T, Mints M, Tham E, Li MJ, Yip SH, Wang J, Bolla MK, Michailidou K, Wang Q, Tyrer JP, Dunlop M, Houlston R, Palles C, Hopper JL, Peto J, Swerdlow AJ, Burwinkel B, Brenner H, Meindl A, Brauch H, Lindblom A, Chang-Claude J, Couch FJ, Giles GG, Kristensen VN, Cox A, Cunningham JM, Pharoah PDP, Dunning AM, Edwards SL, Easton DF, Tomlinson I, Spurdle AB, Five endometrial cancer risk loci identified through genome-wide association analysis. NAT GENET 2016;48 (6):667-+ [PubMed]
Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, Marth C, Nout R, Querleu D, Mirza MR, Sessa C [Contributors: Abal M, Altundag O, Amant F, van Leeuwenhoek A, Banerjee S, Bosse T, Casado A, de Agustín LC, Cibula D, Colombo N, Creutzberg C, del Campo JM, Emons G, Goffin F, González-Martín A, Greggi S, Haie-Meder C, Katsaros D, Kesic V, Kurzeder C, Lax S, Lécuru F, Ledermann J, Levy T, Lorusso D, Mäenpää J, Marth C, Matias-Guiu X, Morice P, Nijman HW, Nout R, Powell M, Querleu D, Mirza MR, Reed N, Rodolakis A, Salvesen H, Sehouli J, Sessa C, Taylor A, Westermann A, Zeimet AG]] , ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up. ANN ONCOL 2016;27 (1):16-41 [PubMed]
Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, Marth C, Nout R, Querleu D, Mirza MR, Sessa C, ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer Diagnosis, Treatment and Follow-up. INT J GYNECOL CANCER 2016;26 (1):2-30 [PubMed]
Coosemans A, Tuyaerts S, Morias K, Corthals J, Heirman C, Thielemans K, van Gool SW, Vergote I, Amant F, mRNA Electroporation of Dendritic Cells with WT1, Survivin, and TriMix (a Mixture of caTLR4, CD40L, and CD70). METHODS MOL BIOL 2016;1428:277-283 [PubMed]
de Haan J, Vandecaveye V, Han SN, van de Vijver KK, Amant F, Difficulties with diagnosis of malignancies in pregnancy. BEST PRACT RES CL OB 2016;33:19-32 [PubMed]
Dewaele M, Tabaglio T, Willekens K, Bezzi M, teo SX, Low DHP, Koh CM, Rambow F, Fiers M, Rogiers A, Radaelli E, Al-Haddawi M, Tan SY, Hermans E, Amant F, Yan H, Lakshmanan M, Koumar RC, Lim ST, Derheimer FA, Campbell RM, Bonday Z, Tergaonkar V, Shackleton M, Blattner C, Marine JC, Guccione E, Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth. J CLIN INVEST 2016;126 (1):68-84 [PubMed]
Froyman W, Landolfo C, Amant F, van den Bosch T, Vergote I, Coosemans A, Testa A, Valentin L, Bourne T, van Calster B, Timmerman D, Morcellation and risk of malignancy in presumed ovarian fibromas/fibrothecomas. LANCET ONCOL 2016;17 (3):273-274 [PubMed]
Haesen D, Abbasi Asbagh L, Derua R, Hubert A, Schrauwen S, Hoorne Y, Amant F, Waelkens E, Sablina A, Janssens V, Recurrent PPP2R1A Mutations in Uterine Cancer Act through a Dominant-Negative Mechanism to Promote Malignant Cell Growth. CANCER RES 2016;76 (19):5719-5731 [PubMed]
Hermans E, van der Merwe SW, Depreeuw J, Dekervel J, Radaelli E, Roskams T, van Pelt Jos J, Topal B, Verslype C, Prenen H, van Steenbergen W, Nevens F, Lambrechts D, Amant F, Successful application of endoscopic ultrasound-guided fine needle biopsy to establish pancreatic patient-derived tumor xenografts: a pilot study. ENDOSCOPY 2016;48 (11):1016-1022 [PubMed]
Koskas M, Depreeuw J, Moens S, Annibali D, Cuppens T, Moerman P, Lambrechts D, Amant F, Genomic Characterisation and Response to Trastuzumab and Paclitaxel in Advanced or Recurrent HER2-positive Endometrial Carcinoma. ANTICANCER RES 2016;36 (10):5381-5384 [PubMed]
Koskas M, Fournier M, Vanderstraeten A, Walker F, Timmerman D, Vergote I, Amant F, Evaluation of models to predict lymph node metastasis in endometrial cancer: A multicentre study. EUR J CANCER 2016;61:52-60 [PubMed]
Koskas M, Huchon C, Amant F, Characteristics and prognosis of patients with early-stage endometrial cancer who refuse adjuvant radiotherapy. GYNECOL ONCOL 2016;141 (3):428-433 [PubMed]
Koskas M, Jozwiak M, Fournier M, Vergote I, Trum H, Lok C, Amant F, Long-term oncological safety of minimally invasive surgery in high-risk endometrial cancer. EUR J CANCER 2016;65:185-191 [PubMed]
Koskas M, Uzan J, Vanderstraeten A, Vergote I, Amant F, External validation of non-imaging models for predicting distant metastasis in patients with endometrial cancer. GYNECOL ONCOL 2016;142 (1):83-88 [PubMed]
Leucci E, Vendramin R, Spinazzi M, Laurette P, Fiers M, Wouters J, Radaelli E, Eyckerman S, Leonelli C, Vanderheyden K, Rogiers A, Hermans E, Baatsen P, Aerts S, Amant F, van Aelst S, van den Oord J, de Strooper B, Davidson I, Lafontaine DLJ, Gevaert K, Vandesompele J, Mestdagh P, Marine JC, Melanoma addiction to the long non-coding RNA SAMMSON. NATURE 2016;531 (7595):518-+ [PubMed]
Limentani SA, Campone M, Dorval T, Curigliano G, de Boer R, Vogel C, White S, Bachelot T, Canon JL, Disis M, Awada A, Berlière M, Amant F, Levine E, Burny W, Callegaro A, de Sousa Alves PM, Louahed J, Brichard V, Lehmann FF, A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors. BREAST CANCER RES TR 2016;156 (2):319-330 [PubMed]
Lishner M, Avivi I, Apperley JF, Dierickx D, Evens AM, Fumagalli M, Nulman I, Oduncu FS, Peccatori FA, Robinson S, van Calsteren K, Vandenbroucke T, van den Heuvel F, Amant F, Hematologic Malignancies in Pregnancy: Management Guidelines From an International Consensus Meeting. J CLIN ONCOL 2016;34 (5):501-+ [PubMed]
Michielsen KLM, Vergote I, Dresen R, Op de Beeck K, Vanslembrouck R, Amant F, Leunen K, Moerman P, Fieuws S, de Keyzer F, Vandecaveye V, Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study. BRIT J RADIOL 2016;89 (1067):20160468 [PubMed]
Moerman P, Amant F, Vergote I, Mesonephric (Wolffian) Pseudoendometrioid Carcinoma of the Broad Ligament, Arising From a Papillary Cystadenoma. INT J SURG PATHOL 2016;24 (7):635-639 [PubMed]
Painter JN, O'Mara TA, Marquart L, Webb PM, Attia J, Medland SE, Cheng T, Dennis J, Holliday EG, McEvoy M, Scott RJ, Ahmed S, Healey CS, Shah M, Gorman M, Martin L, Hodgson SV, Beckmann MW, Ekici AB, Fasching PA, Hein A, Rübner M, Czene K, Darabi H, Hall P, Li J, Dörk T, Dürst M, Hillemanns P, Runnebaum IB, Amant F, Annibali D, Depreeuw J, Lambrechts D, Neven P, Cunningham JM, Dowdy SC, Goode EL, Fridley BL, Winham SJ, Njølstad TS, Salvesen HB, Trovik J, Werner HMJ, Ashton KA, Otton G, Proietto A, Mints M, Tham E, Bolla MK, Michailidou K, Wang Q, Tyrer JP, Hopper JL, Peto J, Swerdlow AJ, Burwinkel B, Brenner H, Meindl A, Brauch H, Lindblom A, Chang-Claude J, Couch FJ, Giles GG, Kristensen VN, Cox A, Pharoah PDP, Tomlinson I, Dunning AM, Easton DF, Thompson DJ, Spurdle AB, Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist: Hip Ratio, Is Causal for Endometrial Cancer. CANCER EPIDEM BIOMAR 2016;25 (11):1503-1510 [PubMed]
Thienpont B, Steinbacher J, Zhao H, D'Anna F, Kuchnio A, Ploumakis A, Ghesquière B, van Dyck L, Boeckx B, Schoonjans L, Hermans E, Amant F, Kristensen VN, Koh KP, Mazzone M, Coleman ML, Carell T, Carmeliet P, Lambrechts D, Tumour hypoxia causes DNA hyper-methylation by reducing TET activity. NATURE 2016;537 (7618):63-68 [PubMed]
Thompson DJ, O'Mara TA, Glubb DM, Painter JN, Cheng T, Folkerd E, Doody D, Dennis J, Webb PM, Gorman M, Martin L, Hodgson S, Michailidou K, Tyrer JP, Maranian MJ, Hall P, Czene K, Darabi H, Li J, Fasching PA, Hein A, Beckmann MW, Ekici AB, Dörk T, Hillemanns P, Dürst M, Runnebaum I, Zhao H, Depreeuw J, Schrauwen S, Amant F, Goode EL, Fridley BL, Dowdy SC, Winham SJ, Salvesen HB, Trovik J, Njolstad TS, Werner HMJ, Ashton K, Proietto T, Otton G, Carvajal-Carmona L, Tham E, Liu T, Mints M, Scott RJ, McEvoy M, Attia J, Holliday EG, Montgomery GW, Martin NG, Nyholt DR, Henders AK, Hopper JL, Traficante N, Ruebner M, Swerdlow AJ, Burwinkel B, Brenner H, Meindl A, Brauch H, Lindblom A, Lambrechts D, Chang-Claude J, Couch FJ, Giles GG, Kristensen VN, Cox A, Bolla MK, Wang Q, Bojesen SE, Shah M, Luben R, Khaw KT, Pharoah PDP, Dunning AM, Tomlinson I, Dowsett M, Easton DF, Spurdle AB, CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer. ENDOCR-RELAT CANCER 2016;23 (2):77-91 [PubMed]
Vancraeynest E, Moerman P, Leunen K, Amant F, Neven P, Vergote I, Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors. INT J GYNECOL CANCER 2016;26 (8):1399-1406 [PubMed]
Vandenbroucke T, van Calsteren K, Amant F, Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy Reply. NEW ENGL J MED 2016;374 (7):693 [PubMed]
van der Putten LJ, Visser NC, van de Vijver K, Santacana M, Bronsert P, Bulten J, Hirschfeld M, Colas E, Gil-Moreno A, Garcia A, Mancebo G, Alameda F, Trovik J, Kopperud RK, Huvila J, Schrauwen S, Koskas M, Walker F, Weinberger V, Minar L, Jandakova E, Snijders MP, van den Berg-van Erp S, Matias-Guiu X, Salvesen HB, Amant F, Massuger LF, Pijnenborg JM, L1CAM expression in endometrial carcinomas: an ENITEC collaboration study. BRIT J CANCER 2016;115 (6):716-724 [PubMed]
Vanderstraeten A, Tuyaerts S, Everaert T, van Bree R, Verbist G, Luyten C, Amant F, In Vitro Assessment of the Expression and T Cell Immunogenicity of the Tumor-Associated Antigens BORIS, MUC1, hTERT, MAGE-A3 and Sp17 in Uterine Cancer. INT J MOL SCI 2016;ahead of print [PubMed]
Vercruysse DCM, Deprez S, Sunaert S, van Calsteren K, Amant F, Effects of prenatal exposure to cancer treatment on neurocognitive development, a review. NEUROTOXICOLOGY 2016;54:11-21 [PubMed]
Aerts L, Enzlin P, Verhaeghe J, Poppe W, Vergote I, Amant F, Sexual Functioning in Women after Surgical Treatment for Endometrial Cancer: A Prospective Controlled Study. J SEX MED 2015;12 (1):198-209 [PubMed]
Amant F, Han SN, Gziri MM, Vandenbroucke T, Verheecke M, van Calsteren K, Management of cancer in pregnancy. BEST PRACT RES CL OB 2015;29 (5):741-753 [PubMed]
Amant F, Lorusso D, Mustea A, Duffaud F, Pautier P, Management Strategies in Advanced Uterine Leiomyosarcoma: Focus on Trabectedin. SARCOMA 2015;2015:704124 [PubMed]
Amant F, Mirza MR, Koskas M, Creutzberg CL, Cancer of the corpus uteri. INT J GYNECOL OBSTET 2015;131 (2):S96-S104 [PubMed]
Amant F, van den Bosch T, Vergote I, Timmerman D, Morcellation of uterine leiomyomas: a plea for patient triage. LANCET ONCOL 2015;16 (15):1454-1456 [PubMed]
Amant F, Vandenbroucke T, Verheecke M, Fumagalli M, Halaska MJ, Boere I, Han S, Gziri MM, Peccatori F, Rob L, Lok C, Witteveen P, Voigt JU, Naulaers G, Vallaeys L, van den Heuvel F, Lagae L, Mertens L, Claes L, van Calsteren K, Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy. NEW ENGL J MED 2015;373 (19):1824-1834 [PubMed]
Amant F, Verheecke M, Wlodarska I, Dehaspe L, Brady P, Brison N, van den Bogaert K, Dierickx D, Vandecaveye V, Tousseyn T, Moerman P, Vanderstichele A, Vergote I, Neven P, Berteloot P, Putseys K, Danneels L, Vandenberghe P, Legius E, Vermeesch JR, Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing. JAMA ONCOL 2015;1 (6):814-819 [PubMed]
Carvajal-Carmona LG, O'Mara TA, Painter JN, Lose FA, Dennis J, Michailidou K, Tyrer JP, Ahmed S, Ferguson K, Healey CS, Pooley K, Beesley J, Cheng T, Jones A, Howarth K, Martin L, Gorman M, Hodgson S, Wentzensen N, Fasching PA, Hein A, Beckmann MW, Renner SP, Dörk T, Hillemanns P, Dürst M, Runnebaum I, Lambrechts D, Coenegrachts L, Schrauwen S, Amant F, Winterhoff B, Dowdy SC, Goode EL, Teoman A, Salvesen HB, Trovik J, Njolstad TS, Werner HMJ, Scott RJ, Ashton K, Proietto T, Otton G, Wersäll O, Mints M, Tham E, Hall P, Czene K, Liu J, Li J, Hopper JL, Southey MC, Ekici AB, Ruebner M, Johnson N, Peto J, Burwinkel B, Marme F, Brenner H, Dieffenbach AK, Meindl A, Brauch H, Lindblom A, Depreeuw J, Moisse M, Chang-Claude J, Rudolph A, Couch FJ, Olson JE, Giles GG, Bruinsma F, Cunningham JM, Fridley BL, Børresen-Dale AL, Kristensen VN, Cox A, Swerdlow AJ, Orr N, Bolla MK, Wang Q, Weber RP, Chen Z, Shah M, Pharoah PDP, Dunning AM, Tomlinson I, Easton DF, Spurdle AB, Thompson DJ, Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk. HUM GENET 2015;134 (2):231-245 [PubMed]
Cheng THT, Thompson D, Painter J, O'Mara T, Gorman M, Martin L, Palles C, Jones A, Buchanan DD, Ko Win A, Hopper J, Jenkins M, Lindor NM, Newcomb PA, Gallinger S, Conti D, Schumacher F, Casey G, Giles GG, Pharoah P, Peto J, Cox A, Swerdlow A, Couch F, Cunningham JM, Goode EL, Winham SJ, Lambrechts D, Fasching P, Burwinkel B, Brenner H, Brauch H, Chang-Claude J, Salvesen HB, Kristensen V, Darabi H, Li J, Liu T, Lindblom A, Hall P, de Polanco ME, Sans M, Carracedo A, Castellvi-Bel S, Rojas-Martinez A, Aguiar Jnr S, Teixeira MR, Dunning AM, Dennis J, Otton G, Proietto T, Holliday E, Attia J, Ashton K, Scott RJ, McEvoy M, Dowdy SC, Fridley BL, Werner HMJ, Trovik J, Njolstad TS, Tham E, Mints M, Runnebaum I, Hillemanns P, Dörk T, Amant F, Schrauwen S, Hein A, Beckmann MW, Ekici A, Czene K, Meindl A, Bolla MK, Michailidou K, Tyrer JP, Wang Q, Ahmed S, Healey CS, Shah M, Annibali D, Depreeuw J, Al-Tassan NA, Harris R, Meyer BF, Whiffin N, Hosking FJ, Kinnersley B, Farrington SM, Timofeeva M, Tenesa A, Campbell H, Haile RW, Hodgson S, Carvajal-Carmona L, Cheadle JP, Easton D, Dunlop M, Houlston R, Spurdle A, Tomlinson I, Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1. SCI REP-UK 2015;5:17369 [PubMed]
Church DN, Stelloo E, Nout RA, Valtcheva N, Depreeuw J, ter Haar N, Noske A, Amant F, Tomlinson IPM, Wild PJ, Lambrechts D, Jürgenliemk-Schulz IM, Jobsen JJ, Smit VTHBM, Creutzberg CL, Bosse T, Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer. JNCI-J NATL CANCER I 2015;107 (1):dju402 [PubMed]
Coenegrachts L, Garcia-Dios DA, Depreeuw J, Santacana M, Gatius S, Zikan M, Moerman P, Verbist L, Lambrechts D, Matias-Guiu X, Amant F, Mutation profile and clinical outcome of mixed endometrioid-serous endometrial carcinomas are different from that of pure endometrioid or serous carcinomas. VIRCHOWS ARCH 2015;466 (4):415-422 [PubMed]
Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, Marth C, Nout R, Querleu D, Mirza MR, Sessa C [Contributors: Abal M, Altundag O, Amant F, Banerjee S, Bosse T, Casado A, Chiva de Agustín L, Cibula D, Colombo N, Creutzberg C, del Campo JM, Emons G, Goffin F, González-Martín A, Greggi S, Haie-Meder C, Katsaros D, Kesic V, Kurzeder C, Lax S, Lécuru F, Ledermann J, Levy T, Lorusso D, Mäenpää J, Marth C, Matias-Guiu X, Morice P, Nijman HW, Nout R, Powell M, Querleu D, Mirza MR, Reed N, Rodolakis A, Salvesen H, Sehouli J, Sessa C, Taylor A, Westermann A, Zeimet AG]] , ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up. RADIOTHER ONCOL 2015;117 (3):559-581 [PubMed]
Croce S, Ribeiro A, Brulard C, Noel JC, Amant F, Stoeckle E, Devouassoux-Shisheborah M, Floquet A, Arnould L, Guyon F, Mishellany F, Garbay D, Cuppens T, Zikan M, Leroux A, Frouin E, Duvillard P, Terrier P, Farre I, Valo I, MacGrogan GM, Chibon F, Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesions. MODERN PATHOL 2015;28 (7):1001-1010 [PubMed]
Cuppens T, Tuyaerts S, Amant F, Potential Therapeutic Targets in Uterine Sarcomas. SARCOMA 2015;2015:243298 [PubMed]
de Haan J, Verheecke M, Amant F, Management of ovarian cysts and cancer in pregnancy. FACTS VIEWS VIS OBGY 2015;7 (1):25-31 [PubMed]
Depreeuw J, Hermans E, Schrauwen S, Annibali D, Coenegrachts L, Thomas D, Luyckx M, Gutierrez-Roelens I, Debruyne D, Konings K, Moerman P, Vergote I, Lambrechts D, Amant F, Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapies. GYNECOL ONCOL 2015;139 (1):118-126 [PubMed]
Despierre E, Vergote I, Anderson R, Coens C, Katsaros D, Hirsch FR, Boeckx B, Varella-Garcia M, Ferrero A, Ray-Coquard I, Berns EMJJ, Casado A, Lambrechts D, Jimeno A [Contributors: Abraham C, Chesnay L, Amant F, Anderson R, Azzedine A, Benedetto C, Bertelli G, Berteloot P, Berton-Rigaud D, Biglia N, Bonichon-Lamichhane N, Bougnoux P, Bourbouloux E, Bourcier C, Buck M, Campone M, Canuto EM, Casado Herraez A, Cauvin I, Chauvenet L, Chevalier-Place A, Cottu PH, Cretin J, Cumin I, Curé H, Dalenc F, Danese S, Davis A, Debruyne P, Delplanque G, Delva R, D'Hondt V, Dramais D, Durando X, El Kouri C, Esteban C, Fabbro M, Falandry C, Filleul B, Floquet A, Fumoleau P, Garcia-Varella M, Garnier C, Gilby E, Gladieff L, Goffin F, Gouttebel MC, Green JA, Guastalla JP, Hardy-Bessard AC, Hirsch F, Hughes A, Jaubert D, Kaminsky MC, Katsaros D, Largillier R, Lebrun- Jezekova D, Leduc B, Leheurteur M, Lesoin A, Leunen K, Levasseur N, Leyronnas C, Llory JF, Lortholary A, Mayer F, Mayeur D, Mendiola C, Mignot L, Morgan J, Mouret-Reynier MA, Neven P, Petit T, Picardo E, Plaza J, Pluvio-Coronado M, Priou F, Pujade-Lauraine E, Coquard IR, Reed N, Rigault de la Longrais I, Scholl S, Sillet-Bach I, Steer C, Summers J, Trillet-Lenoir V, van Dam P, van der Burg MEL, Vanlerenberghe E, Vannetzel JM, Vergote I, Aragon JAV, Waters J, Weber B, Yazbek G, Zola P]] , Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy. TARGET ONCOL 2015;10 (4):583-596 [PubMed]
Han S. Breast cancer during pregnancy: staging, treatment and maternal prognosis. S.l.: s.n.; 2015. 236p. Proefschrift KU Leuven, Faculty of Medicine. (Promotor(s): Amant FCH; copromotor(s): Loibl S)
Han SN, van Peer S, Peccatori F, Gziri MM, Amant F, Contraception is as important as fertility preservation in young women with cancer. LANCET 2015;385 (9967):508 [PubMed]
Koskas M, Rouzier R, Amant F, Staging for endometrial cancer: The controversy around lymphadenectomy - Can this be resolved?. BEST PRACT RES CL OB 2015;29 (6):845-857 [PubMed]
Lambrechts S, Lambrechts D, Despierre E, van Nieuwenhuysen E, Smeets D, Debruyne PR, Renard V, Vroman P, Luyten D, Neven P, Amant F, Leunen K, Vergote I, Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer. BMC PHARMACOL TOXICO 2015;16:2 [PubMed]
Loibl S, Schmidt A, Gentilini O, Kaufman B, Kuhl C, Denkert C, von Minckwitz G, Parokonnaya A, Stensheim H, Thomssen C, van Calsteren K, Poortmans P, Berveiller P, Markert UR, Amant F, Breast Cancer Diagnosed During Pregnancy Adapting Recent Advances in Breast Cancer Care for Pregnant Patients. JAMA ONCOL 2015;1 (8):1145-1153 [PubMed]
Njølstad TS, Trovik J, Hveem TS, Kjæreng ML, Kildal W, Pradhan M, Marcickiewicz J, Tingulstad S, Staff AC, Haugland HK, Eraker R, Oddenes K, Rokne JA, Tjugum J, Lode MS, Amant F, Werner HM, Salvesen HB, Danielsen HE, DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer. BRIT J CANCER 2015;112 (10):1656-1664 [PubMed]
O'Mara TA, Glubb DM, Painter JN, Cheng T, Dennis J, Attia J, Holliday EG, McEvoy M, Scott RJ, Ashton K, Proietto T, Otton G, Shah M, Ahmed S, Healey CS, Gorman M, Martin L, Hodgson S, Fasching PA, Hein A, Beckmann MW, Ekici AB, Hall P, Czene K, Darabi H, Li J, Dürst M, Runnebaum I, Hillemanns P, Dörk T, Lambrechts D, Depreeuw J, Annibali D, Amant F, Zhao H, Goode EL, Dowdy SC, Fridley BL, Winham SJ, Salvesen HB, Njølstad TS, Trovik J, Werner HMJ, Tham E, Liu T, Mints M, Bolla MK, Michailidou K, Tyrer JP, Wang Q, Hopper JL, Peto J, Swerdlow AJ, Burwinkel B, Brenner H, Meindl A, Brauch H, Lindblom A, Chang-Claude J, Couch FJ, Giles GG, Kristensen VN, Cox A, Pharoah PDP, Dunning AM, Tomlinson I, Easton DF, Thompson DJ, Spurdle AB, Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer. ENDOCR-RELAT CANCER 2015;22 (5):851-861 [PubMed]
Painter JN, O'Mara TA, Batra J, Cheng T, Lose FA, Dennis J, Michailidou K, Tyrer JP, Ahmed S, Ferguson K, Healey CS, Kaufmann S, Hillman KM, Walpole C, Moya L, Pollock P, Jones A, Howarth K, Martin L, Gorman M, Hodgson S, de Polanco MME, Sans M, Carracedo A, Castellvi-Bel S, Rojas-Martinez A, Santos E, Teixeira MR, Carvajal-Carmona L, Shu XO, Long J, Zheng W, Xiang YB, Montgomery GW, Webb PM, Scott RJ, McEvoy M, Attia J, Holliday E, Martin NG, Nyholt DR, Henders AK, Fasching PA, Hein A, Beckmann MW, Renner SP, Dörk T, Hillemanns P, Dürst M, Runnebaum I, Lambrechts D, Coenegrachts L, Schrauwen S, Amant F, Winterhoff B, Dowdy SC, Goode EL, Teoman A, Salvesen HB, Trovik J, Njolstad TS, Werner HMJ, Ashton K, Proietto T, Otton G, Tzortzatos G, Mints M, Tham E, Hall P, Czene K, Liu J, Li J, Hopper JL, Southey MC, Ekici AB, Ruebner M, Johnson N, Peto J, Burwinkel B, Marme F, Brenner H, Dieffenbach AK, Meindl A, Brauch H, Lindblom A, Depreeuw J, Moisse M, Chang-Claude J, Rudolph A, Couch FJ, Olson JE, Giles GG, Bruinsma F, Cunningham JM, Fridley BL, Børresen-Dale AL, Kristensen VN, Cox A, Swerdlow AJ, Orr N, Bolla MK, Wang Q, Weber RP, Chen Z, Shah M, French JD, Pharoah PDP, Dunning AM, Tomlinson I, Easton DF, Edwards SL, Thompson DJ, Spurdle AB [Contributors: Spurdle AB, Webb PM, Young J, McQuire L, Baron-Hay S, Bell D, Bonaventura A, Brand A, Braye S, Carter J, Chan F, Dalrymple C, Ferrier A, Gard G, Hacker N, Hogg R, Houghton R, Marsden D, McIlroy K, Otton G, Pather S, Proietto A, Robertson G, Scurry J, Sharma R, Wain G, Wong F, Armes J, Crandon A, Cummings M, Land R, Nicklin J, Perrin L, Obermair A, Ward B, Davy M, Dodd T, Miller J, Oehler M, Paramasivum S, Pierides J, Whitehead F, Blomfield P, Challis D, Neesham D, Pyman J, Quinn M, Rome R, Weitzer M, Brennan B, Hammond I, Leung Y, McCartney A, Stewart C, Thompson J, O'Brien S, Moore S, Ferguson K, Walsh M, Cicero R, Green L, Griffith J, Jackman L, Ranieri B, O'Brien M, Schultz P, Alexander B, Baxter C, Croy H, Fitzgerald A, Herron E, Hill C, Jones M, Maidens J, Marshall A, Martin K, Mayhew J, Minehan E, Roffe D, Shirley H, Steane H, Stenlake A, Ward A, Webb S, White J, de Polanco MME, Bohórquez ME, Prieto R, Criollo A, Ramírez C, Estrada AP, Suárez JJ, Martinez AR, Rogatto S, Jnr SA, Santos EMM, Sans M, Colistro V, Hidalgo PC, Mut P, Carracedo A, Ponte CR, Garcia IQ, Castellvi-Bel S, Teixeira M, de Almeida AB, Hamann U, Gilbert M, Tomlinson I, Adams M, Al-Samarraie A, Anwar S, Athavale R, Awad S, Bali A, Barnes A, Cawdell G, Chan S, Chin K, Cornes P, Crawford M, Cullimore J, Ghaem-Maghami S, Gornall R, Green J, Hall M, Harvey M, Hawe J, Head A, Herod J, Hingorani M, Hocking M, Holland C, Hollingsworth T, Hollingworth J, Ind T, Irvine R, Irwin C, Katesmark M, Kehoe S, Kheng-Chew G, Lankester K, Linder A, Luesley D, B-Lynch C, McFarlane V, Naik R, Nicholas N, Nugent D, Oates S, Oladipo A, Papadopoulos A, Pearson S, Radstone D, Raju S, Rathmell A, Redman C, Rymer M, Sarhanis P, Sparrow G, Stuart N, Sundar S, Thompson A, Tinkler S, Trent S, Tristram A, Walji N, Woolas R, Lindblom A, Tzortzatos G, Mints M, Tham E, Castro O, Gemzell-Danielsson K, Baker H, Baynes C, Conroy D, Curzon B, Harrington P, Irvine S, Luccarini C, Mayes R, Munday H, Perkins B, Pharoah D, Platte R, Stafford A, West J, Shu XO, Zheng W, Long J, Cai Q, Dai Q, Cai H, Delahanty R, Li C, Xiang YB, Gao Y, Xu WH, Lu W, Zheng Y, Gu K, Stuart-Harris R, Kirsten F, Rutovitz J, Clingan P, Glasgow A, Shannon J, Bonaventura T, Stewart J, Begbie S, Friedlander M, Nevell D, Pavlakis N, Valmadre S, Young B, Camaris C, Crouch R, Edwards L, Beale P, Beith J, Russell P, Anderson L, Links M, Grygiel J, Hill J, Byth K, Jaworski R, Harnett P, Purdie D, Whiteman D, Papadimos D, Horwood K, Wyld D, Oehler MK, Hall C, Healy T, Pittman K, Henderson D, Pierdes J, Achan A, McIntosh R, Parker A, Brown B, Allen D, Grant P, Hyde S, Robbie RLM, Healy D, Jobling T, Manolitsas T, McNealage J, Rogers P, Susil B, Sumithran E, Simpson I, Haviv I, Phillips K, Rischin D, Fox S, Johnson D, Lade S, Waring P, Loughrey M, O'Callaghan N, Murray B, Mileshkin L, Allan P, Billson V, Hamilton A, Underhill C, Bell R, Ng LF, Blum R, Ganju V, Buck M, Zeps N, Bowtell DDL, Green AC, Chenevix-Trench G, deFazio A, Gertig D, Bugert P, Arndt V, Müller H, Stegmaier C, Lo WY, Justenhoven C, Brüning T, Pesch B, Ko YD, Rabstein S, Lotz A, Baisch C, Fischer HP, Harth V]] , Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk. HUM MOL GENET 2015;24 (5):1478-1492 [PubMed]
Radaelli E, Hermans E, Omodho L, Francis A, Vander Borght S, Marine JC, van den Oord J, Amant F, Spontaneous Post-Transplant Disorders in NOD.Cg- Prkdc(scid) Il2rg(tm1Sug)/JicTac (NOG) Mice Engrafted with Patient-Derived Metastatic Melanomas. PLOS ONE 2015;10 (5):e0124974 [PubMed]
Schrauwen S. Establishment of preclinical endometrial carcinoma models and evaluation of new treatment options. S.l.: s.n.; 2015. -p. Proefschrift KU Leuven, Faculty of Medicine. (Promotor(s): Amant FCH; copromotor(s): Lambrechts D)
Schrauwen S, Coenegrachts L, Cattaneo A, Hermans E, Lambrechts D, Amant F, The antitumor effect of metformin with and without carboplatin on primary endometrioid endometrial carcinoma in vivo. GYNECOL ONCOL 2015;138 (2):378-382 [PubMed]
Schrauwen S, Coenegrachts L, Depreeuw J, Luyten C, Verbist G, Debruyne D, Vergote I, Lambrechts D, Amant F, Microsatellite Instable and Microsatellite Stable Primary Endometrial Carcinoma Cells and Their Subcutaneous and Orthotopic Xenografts Recapitulate the Characteristics of the Corresponding Primary Tumor. INT J GYNECOL CANCER 2015;25 (3):363-371 [PubMed]
Schrauwen S, Depreeuw J, Coenegrachts L, Hermans E, Lambrechts D, Amant F, Dual blockade of PI3K/AKT/mTOR (NVP-BEZ235) and Ras/Raf/MEK (AZD6244) pathways synergistically inhibit growth of primary endometrioid endometrial carcinoma cultures, whereas NVP-BEZ235 reduces tumor growth in the corresponding xenograft models. GYNECOL ONCOL 2015;138 (1):165-173 [PubMed]
van Dam L, Han SN, Dierickx D, Amant F, Optimal staging of lymphoma during pregnancy is crucial. WOMENS HEALTH (LOND ENGL) 2015;11 (2):101-102 [PubMed]
Vandenberghe P, Wlodarska I, Tousseyn T, Dehaspe L, Dierickx D, Verheecke M, Uyttebroeck A, Bechter O, Delforge M, Vandecaveye V, Brison N, Verhoef GEG, Legius E, Amant F, Vermeesch JR, Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study. LANCET HAEMATOL 2015;2 (2):E55-E65 [PubMed]
Vandenbroucke T, Amant F, Development of children born to mothers with cancer during pregnancy: comparing in utero chemotherapy-exposed children with nonexposed controls. AM J OBSTET GYNECOL 2015;212 (6):830-831 [PubMed]
Vandeperre A, van Limbergen E, Leunen K, Moerman P, Amant F, Vergote I, Para-aortic lymph node metastases in locally advanced cervical cancer: Comparison between surgical staging and imaging. GYNECOL ONCOL 2015;138 (2):299-303 [PubMed]
Vanderstraeten A, Everaert T, van Bree R, Verbist G, Luyten C, Amant F, Tuyaerts S, In Vitro Validation of Survivin as Target Tumor-associated Antigen for Immunotherapy in Uterine Cancer. J IMMUNOTHER 2015;38 (6):239-249 [PubMed]
Vanderstraeten A, Tuyaerts S, Amant F, The immune system in the normal endometrium and implications for endometrial cancer development. J REPROD IMMUNOL 2015;109:7-16 [PubMed]
Vergote I, Debruyne P, Kridelka F, Berteloot P, Amant F, Honhon B, Lybaert W, Leunen K, Geldhof K, Verhoeven D, Forget F, Vuylsteke P, D'Hondt L, Huizing M, van den Bulck H, Laenen A, Phase II study of weekly paclitaxel/carboplatin in combination with prophylactic G-CSF in the treatment of gynecologic cancers: A study in 108 patients by the Belgian Gynaecological Oncology Group. GYNECOL ONCOL 2015;138 (2):278-284 [PubMed]
Aerts L. Sexual, psychological and relational functioning in women after surgical treatment for gynaecological cancer and breast. S.l.: s.n.; 2014. 214p. Proefschrift KU Leuven, Faculty of Medicine. (Promotor(s): Amant FCH; copromotor(s): Enzlin P, Christiaens MR)
Aerts L, Christiaens MR, Enzlin P, Neven P, Amant F, Sexual functioning in women after mastectomy versus breast conserving therapy for early-stage breast cancer: A prospective controlled study. BREAST 2014;23 (5):629-636 [PubMed]
Aerts L, Enzlin P, Verhaeghe J, Poppe W, Vergote I, Amant F, Long-Term Sexual Functioning in Women After Surgical Treatment of Cervical Cancer Stages IA to IB A Prospective Controlled Study. INT J GYNECOL CANCER 2014;24 (8):1527-1534 [PubMed]
Aerts L, Enzlin P, Verhaeghe J, Vergote I, Amant F, Psychologic, Relational, and Sexual Functioning in Women After Surgical Treatment of Vulvar Malignancy A Prospective Controlled Study. INT J GYNECOL CANCER 2014;24 (2):372-380 [PubMed]
Alonso-Alconada L, Muinelo-Romay L, Madissoo K, Diaz-Lopez A, Krakstad C, Trovik J, Wik E, Hapangama D, Coenegrachts L, Cano A, Gil-Moreno A, Chiva L, Cueva J, Vieito M, Ortega E, Mariscal J, Colas E, Castellvi J, Cusido M, Dolcet X, Nijman HW, Bosse T, Green JA, Romano A, Reventos J, Lopez-Lopez R, Salvesen HB, Amant F, Matias-Guiu X, Moreno-Bueno G, Abal M, Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer. MOL CANCER 2014;13:223 [PubMed]
Amant F, Floquet A, Friedlander M, Kristensen G, Mahner S, Nam EJ, Powell MA, Ray-Coquard I, Siddiqui N, Sykes P, Westermann AM, Seddon B, Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma. INT J GYNECOL CANCER 2014;24 (9 Suppl 3):S67-S72 [PubMed]
Amant F, Halaska MJ, Fumagalli M, Dahl Steffensen K, Lok C, van Calsteren K, Han SN, Mir O, Fruscio R, Uzan C, Maxwell C, Dekrem J, Strauven G, Mhallem Gziri M, Kesic V, Berveiller P, van den Heuvel F, Ottevanger PB, Vergote I, Lishner M, Morice P, Nulman I, Gynecologic Cancers in Pregnancy Guidelines of a Second International Consensus Meeting. INT J GYNECOL CANCER 2014;24 (3):394-403 [PubMed]
Bauters T, Laekeman G, Amant F, Robays H, Benoit Y, Mondelaers V, Breastfeeding a child on treatment for childhood cancer. J ONCOL PHARM PRACT 2014;20 (3):237-238 [PubMed]
Binda MM, Corona R, Amant F, Koninckx PR, Conditioning of the abdominal cavity reduces tumor implantation in a laparoscopic mouse model. SURG TODAY 2014;44 (7):1328-1335 [PubMed]
Coosemans A, Tuyaerts S, Vanderstraeten A, Vergote I, Amant F, van Gool SW, Dendritic cell immunotherapy in uterine cancer. HUM VACC IMMUNOTHER 2014;10 (7):1822-1827 [PubMed]
Deprez S, Vandenbulcke M, Peeters R, Emsell L, Smeets A, Christiaens MR, Amant F, Sunaert S, Longitudinal Assessment of Chemotherapy-Induced Alterations in Brain Activation During Multitasking and Its Relation With Cognitive Complaints. J CLIN ONCOL 2014;32 (19):2031-U72 [PubMed]
Despierre E, Moisse M, Yesilyurt B, Sehouli J, Braicu I, Mahner S, Castillo-Tong DC, Zeillinger R, Lambrechts S, Leunen K, Amant F, Moerman P, Lambrechts D, Vergote I, Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancer. GYNECOL ONCOL 2014;135 (3):415-422 [PubMed]
Despierre E, Yesilyurt BT, Lambrechts S, Johnson N, Verheijen R, van der Burg M, Casado A, Rustin G, Berns E, Leunen K, Amant F, Moerman P, Lambrechts D, Vergote I [Contributors: Angioli R, Panici PB, Bentley J, Berteloot P, Bessette P, Boman K, Buist M, Chan K, Chan S, Coronado Martín P, Counsell R, Cruickshank DJ, Davis J, de Greve J, de Oliveira CF, de Valk B, Dittrich C, Ehlen T, Elit L, Favalli G, Floquet A, Gauthier P, Gerdin E, Ghatage P, Gilby E, Gleeson N, Gotlieb W, Green JA, Grimshaw R, Heywood M, Hirsch V, Hoekman K, Honkoop A, Hoskins P, Kannisto P, Kaern J, Katsaros D, Kenter GG, Kieser K, Kristeller TV, Kristensen GB, Lacave AJ, Leblanc E, Ledermann J, Lotocki R, Maggino T, Marth C, Martin L, Massuger L, Mendiola C, Miller D, Mosgaard B, Mota F, Neven P, Nooij M, Nordal R, Nordin A, Ottevanger PB, Papadopoulos A, Pecorelli S, Petru E, Plante M, Popadiuk C, Provencher D, Reed NS, Redman C, Roozendaal KJ, Sadozye AH, Sandvei R, Seoane JM, Sereni MI, Sert B, Siddiqui N, Speiser P, Stuart GCE, Tholander B, Tognon G, Trimbos B, Tropé CG, Trudeau M, van Baal M, van Doorn HC, van der Velden J, van Eygen K, Vermorken JB, Vidart Aragon JA, Wensveen CWM, Zola P, Anastosopoulou A, Bethe U, Coens C, Dehaes K, Demeester A, Demonty G, de Heusch E, de Rouck M, Giurgea L, Hoctin-Boes G, Teodorovic I, Ven K, Verleye L, van Luijk I, Bacon M, Eisenhauer E]] , Epithelial Ovarian Cancer Rationale for Changing the One- Fits- All Standard Treatment Regimen to Subtype- Specific Treatment. INT J GYNECOL CANCER 2014;24 (3):468-477 [PubMed]
Dewaele B, Przybyl J, Quattrone A, Finalet Ferreiro J, Vanspauwen V, Geerdens E, Gianfelici V, Kalender Z, Wozniak A, Moerman P, Sciot R, Croce S, Amant F, Vandenberghe P, Cools J, Debiec-Rychter M, Identification of a novel, recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcoma. INT J CANCER 2014;134 (5):1112-1122 [PubMed]
Han SN, Loibl S, van Calster B, Neven P, Nekljudova V, Amant F, Prognosis of Women With Primary Breast Cancer Diagnosed During Pregnancy Reply. J CLIN ONCOL 2014;32 (3):255-256 [PubMed]
Han SN, Verheecke M, Vandenbroucke T, Gziri MM, van Calsteren K, Amant F, Management of Gynecological Cancers During Pregnancy. CURR ONCOL REP 2014;16 (12):415 [PubMed]
Heitz F, Amant F, Fotopoulou C, Battista MJ, Wimberger P, Traut A, Fisseler-Eckhoff A, Harter P, Vandenput I, Sehouli J, Schmidt M, Kimmig R, du Bois R, du Bois A, Synchronous Ovarian and Endometrial Cancer-an International Multicenter Case-Control Study. INT J GYNECOL CANCER 2014;24 (1):54-60 [PubMed]
Hidalgo M, Amant F, Biankin AV, Budinská E, Byrne AT, Caldas C, Clarke RB, de Jong S, Jonkers J, Mælandsmo GM, Roman-Roman S, Seoane J, Trusolino L, Villanueva A, Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research. CANCER DISCOV 2014;4 (9):998-1013 [PubMed]
Madondo MT, Tuyaerts S, Turnbull BB, Vanderstraeten A, Kohrt H, Narasimhan B, Amant F, Quinn M, Plebanski M, Variability in CRP, regulatory T cells and effector T cells over time in gynaecological cancer patients: a study of potential oscillatory behaviour and correlations. J TRANSL MED 2014;12:179 [PubMed]
Maiques O, Cuevas D, García Dios DA, Coenegrachts L, Santacana M, Velasco A, Romero M, Sónia G, Lambrechts D, Dolcet X, Amant F, Matias-Guiu X, FISH analysis of PTEN in endometrial carcinoma. Comparison with SNP arrays and MLPA. HISTOPATHOLOGY 2014;65 (3):371-388 [PubMed]
Maiques O, Santacana M, Valls J, Pallares J, Mirantes C, Gatius S, García Dios DA, Amant F, Pedersen HC, Dolcet X, Matias-Guiu X, Optimal protocol for PTEN immunostaining; role of analytical and preanalyticat variables in PTEN staining in normal and neoplastic endometrial, breast, and prostatic tissues. HUM PATHOL 2014;45 (3):522-532 [PubMed]
Michielsen K, Vergote I, Op de Beeck K, Amant F, Leunen K, Moerman P, Deroose C, Souverijns G, Dymarkowski S, de Keyzer F, Vandecaveye V, Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT. EUR RADIOL 2014;24 (4):889-901 [PubMed]
Partridge AH, Pagani O, Abulkhair O, Aebi S, Amant F, Azim HA Jr, Costa A, Delaloge S, Freilich G, Gentilini OD, Harbeck N, Kelly CM, Loibl S, Meirow D, Peccatori F, Kaufmann B, Cardoso F, First international consensus guidelines for breast cancer in young women (BCY1). BREAST 2014;23 (3):209-220 [PubMed]
Reynders A, Brouckaert O, Smeets A, Laenen A, Yoshihara E, Persyn F, Floris G, Leunen K, Amant F, Soens J, van Ongeval C, Moerman P, Vergote I, Christiaens MR, Staelens G, van Eygen K, Vanneste A, van Dam P, Colpaert C, Neven P, Prediction of non-sentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node. BREAST 2014;23 (4):453-459 [PubMed]
Toesca A, Gentilini O, Peccatori F, Azim HA Jr, Amant F, Locoregional treatment of breast cancer during pregnancy. GYNECOL SURG 2014;11 (4):279-284 [PubMed]
Tomasi-Cont N, Lambertini M, Hulsbosch S, Peccatori AF, Amant F, Strategies for fertility preservation in young early breast cancer patients. BREAST 2014;23 (5):503-510 [PubMed]
Trovik J, Salvesen HB, Cuppens T, Amant F, Staff AC, Growth Differentiation Factor-15 as Biomarker in Uterine Sarcomas. INT J GYNECOL CANCER 2014;24 (2):252-259 [PubMed]
van Calsteren K, Amant F, Cancer during pregnancy. ACTA OBSTET GYN SCAN 2014;93 (5):443-446 [PubMed]
Vandenbroucke T, Verheecke M, van Calsteren K, Han S, Claes L, Amant F, Fetal outcome after prenatal exposure to chemotherapy and mechanisms of teratogenicity compared to alcohol and smoking. EXPERT OPIN DRUG SAF 2014;13 (12):1653-1665 [PubMed]
Vanderstraeten A. Exploration and development of combination immunotherapy as a treatment for uterine cancer. S.l.: s.n.; 2014. 171p. Proefschrift KU Leuven, Faculty of Medicine. (Promotor(s): Amant FCH; copromotor(s): van Gool S, Thielemans K)
Vanderstraeten A, Luyten C, Verbist G, Tuyaerts S, Amant F, Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapy. CANCER IMMUNOL IMMUN 2014;63 (6):545-557 [PubMed]
van Hasselt JGC, van Calsteren K, Heyns L, Han S, Mhallem Gziri M, Schellens JHM, Beijnen JH, Huitema ADR, Amant F, Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel. ANN ONCOL 2014;25 (10):2059-2065 [PubMed]
Verheecke M, Halaska MJ, Lok CA, Ottevanger PB, Fruscio R, Dahl-Steffensen K, Kolawa W, Gziri MM, Han SN, van Calsteren K, van den Heuvel F, de Vleeschouwer S, Clement PM, Menten J, Amant F, Primary brain tumours, meningiomas and brain metastases in pregnancy: Report on 27 cases and review of literature. EUR J CANCER 2014;50 (8):1462-1471 [PubMed]
Zhao H, Thienpont B, Yesilyurt BT, Moisse M, Reumers J, Coenegrachts L, Sagaert X, Schrauwen S, Smeets D, Matthijs G, Aerts S, Cools J, Metcalf A, Spurdle A, Amant F, Lambrechts D, Mismatch repair deficiency endows tumors with a unique mutation signature and sensitivity to DNA double-strand breaks. ELIFE 2014;3:e02725 [PubMed]
Amant F, von Minckwitz G, Han SN, Bontenbal M, Ring AE, Giermek J, Wildiers H, Fehm T, Linn SC, Schlehe B, Neven P, Westenend PJ, Müller V, van Calsteren K, Rack B, Nekljudova V, Harbeck N, Untch M, Witteveen PO, Schwedler K, Thomssen C, van Calster B, Loibl S, Prognosis of Women With Primary Breast Cancer Diagnosed During Pregnancy: Results From an International Collaborative Study. J CLIN ONCOL 2013;31 (20):2532-+ [PubMed]
Boussios S, Han SN, Fruscio R, Halaska MJ, Ottevanger PB, Peccatori FA, Koubková L, Pavlidis N, Amant F, Lung cancer in pregnancy: Report of nine cases from an international collaborative study. LUNG CANCER 2013;82 (3):499-505 [PubMed]
Cadron I, Abdulkadir L, Despierre E, Berteloot P, Neven P, Leunen K, Amant F, Vergote I, The "Leuven" paclitaxel/carboplatin weekly regimen in patients with recurrent ovarian cancer, a retrospective study. GYNECOL ONCOL 2013;128 (1):34-37 [PubMed]
Coenegrachts L, Schrauwen S, van Bree R, Despierre E, Luyten C, Jonckx B, Stassen JM, Vergote I, Amant F, Increased expression of placental growth factor in high-grade endometrial carcinoma. ONCOL REP 2013;29 (2):413-418 [PubMed]
Coosemans A, Vanderstraeten A, Tuyaerts S, Verschuere T, Moerman P, Berneman ZN, Vergote I, Amant F, van Gool SW, Wilms' Tumor Gene 1 (WT1) - loaded Dendritic Cell Immunotherapy in Patients with Uterine Tumors: A Phase I/II Clinical Trial. ANTICANCER RES 2013;33 (12):5495-5500 [PubMed]
Coosemans A, Vanderstraeten A, Tuyaerts S, Verschuere T, Moerman P, Berneman Z, Vergote I, Amant F, van Gool SW, Immunological Response after WT1 mRNA-loaded Dendritic Cell Immunotherapy in Ovarian Carcinoma and Carcinosarcoma. ANTICANCER RES 2013;33 (9):3855-3859 [PubMed]
Dauwen H, van Calster B, Deroose CM, Op de Beeck K, Amant F, Neven P, Berteloot P, Leunen K, Timmerman D, Vergote I, PET/CT in the staging of patients with a pelvic mass suspicious for ovarian cancer. GYNECOL ONCOL 2013;131 (3):694-700 [PubMed]
Dekrem J, van Calsteren K, Amant F, Effects of Fetal Exposure to Maternal Chemotherapy. PEDIATR DRUGS 2013;15 (5):329-334 [PubMed]
Delahanty RJ, Xiang YB, Spurdle A, Beeghly-Fadiel A, Long J, Thompson D, Tomlinson I, Yu H, Lambrechts D, Dörk T, Goodman MT, Zheng Y, Salvesen HB, Bao PP, Amant F, Beckmann MW, Coenegrachts L, Coosemans A, Dubrowinskaja N, Dunning A, Runnebaum IB, Easton D, Ekici AB, Fasching PA, Halle MK, Hein A, Howarth K, Gorman M, Kaydarova D, Krakstad C, Lose F, Lu L, Lurie G, O'Mara T, Matsuno RK, Pharoah P, Risch H, Corssen M, Trovik J, Turmanov N, Wen W, Lu W, Cai Q, Zheng W, Shu XO, Polymorphisms in Inflammation Pathway Genes and Endometrial Cancer Risk. CANCER EPIDEM BIOMAR 2013;22 (2):216-223 [PubMed]
Deprez S. Magnetic Resonance Imaging of the neural substrate of chemotherapy−induced cognitive impairment in patients with breast cancer.. S.l.: s.n.; 2013. 184p. Proefschrift KU Leuven, Faculty of Medicine. (Promotor(s): Sunaert S; copromotor(s): Amant FCH, Vandenbulcke M)
Deprez S, Vandenbulcke M, Peeters R, Emsell L, Amant F, Sunaert S, The functional neuroanatomy of multitasking: Combining dual tasking with a short term memory task. NEUROPSYCHOLOGIA 2013;51 (11):2251-2260 [PubMed]
Despierre E, Lambrechts S, Leunen K, Berteloot P, Neven P, Amant F, O'Shannessy DJ, Somers EB, Vergote I, Folate receptor alpha (FRA) expression remains unchanged in epithelial ovarian and endometrial cancer after chemotherapy. GYNECOL ONCOL 2013;130 (1):192-199 [PubMed]
García Dios DA. Somatic mutations and copy number alterations as prognostic markers for primary endometrial cancer. S.l.: s.n.; 2013. 140p. Proefschrift KU Leuven, Faulty of Medicine. (Promotor(s): Amant FCH; copromotor(s): Lambrechts D)
Garcia-Dios DA, Lambrechts D, Coenegrachts L, Vandenput I, Capoen A, Webb PM, Ferguson K, Akslen LA, Claes B, Vergote I, Moerman P, van Robays J, Marcickiewicz J, Salvesen HB, Spurdle AB, Amant F [Contributors: Webb P, Young J, McQuire L, Baron-Hay S, Bell D, Bonaventura A, Brand A, Braye S, Carter J, Chan F, Dalrymple C, Ferrier A, Gard G, Hacker N, Hogg R, Houghton R, Marsden D, McIlroy K, Otton G, Pather S, Proietto A, Robertson G, Scurry J, Sharma R, Wain G, Wong F, Armes J, Crandon A, Cummings M, Land R, Nicklin J, Perrin L, Obermair A, Ward B, Davy M, Dodd T, Miller J, Oehler M, Paramasivum S, Pierides J, Whitehead F, Blomfield P, Challis D, Neesham D, Pyman J, Quinn M, Rome R, Weitzer M, Brennan B, Hammond I, Leung Y, McCartney A, Stewart C, Thompson J, O'Brien S, Moore S, Ferguson K, Walsh M, Cicero R, Green L, Griffith J, Jackman L, Ranieri B, O'Brien M, Schultz P, Alexander B, Baxter C, Croy H, Fitzgerald A, Herron E, Hill C, Jones M, Maidens J, Marshall A, Martin K, Mayhew J, Minehan E, Roffe D, Shirley H, Steane H, Stenlake A, Ward A, Webb S, White J]] , High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma. GYNECOL ONCOL 2013;128 (2):327-334 [PubMed]
Garçous R, Remy G, Bary M, Amant F, Cauwe F, de Beusscher L, Bouzette A, de Coster P, Hecq JD, Implémentation de la prescription informatisée en milieu hospitalier: quelles sont les clés d'un déploiement réussi ?. J PHARM BELG 2013;2013 (2):32-38 [PubMed]
Gziri MM, Goffin F, Debieve F, Amant F, Cancer pendant la grossesse: importance d'un registre national et Européen. REV MED LIEGE 2013;68 (10):527-530 [PubMed]
Gziri MM, Hui W, Amant F, van Calsteren K, Ottevanger N, Kapusta L, Mertens L, Myocardial function in children after fetal chemotherapy exposure. A tissue Doppler and myocardial deformation imaging study. EUR J PEDIATR 2013;172 (2):163-170 [PubMed]
Gziri MM, Pokreisz P, de Vos R, Verbeken E, Debiève F, Mertens L, Janssens SP, Amant F, Fetal Rat Hearts Do Not Display Acute Cardiotoxicity in Response to Maternal Doxorubicin Treatment. J PHARMACOL EXP THER 2013;346 (3):362-369 [PubMed]
Han SN, Gziri MM, van Calsteren K, Amant F, Is chemotherapy during the first trimester of pregnancy really safe?. INT J CANCER 2013;132 (7):1728 [PubMed]
Han SN, Kesic VI, van Calsteren K, Petkovic S, Amant F [Contributors: Skrzypczyk A, Hasenburg A, Uzan C, Roussy G, Lok C, Benedicic C, Vaitkiene D, Peccatori F, Markowska J, Dahl-Steffensen K, Iraki M, Halaska M, Fumagalli M, Ottevanger N, Pavlidis N, Reed N, Cottier O, Zola P, Panici PB, Kimmig R, Fruscio R, Rouzier R, Loibl S, Lang U, Kolawa W]] , Cancer in pregnancy: a survey of current clinical practice. EUR J OBSTET GYN R B 2013;167 (1):18-23 [PubMed]
Han SN, Mhallem Gziri M, van Calsteren K, Amant F, Cervical cancer in pregnant women: treat, wait or interrupt? Assessment of current clinical guidelines, innovations and controversies. THER ADV MED ONCOL 2013;5 (4):211-219 [PubMed]
Mhallem Gziri M. Cancer treatment during pregnancy: preclinical and clinical assessment of fetal cardiotoxicity. S.l.: s.n.; 2013. 157p. Proefschrift KU Leuven, Faculty of Medicine. (Promotor(s): Amant FCH; copromotor(s): Mertens L, Debieve F)
Mhallem Gziri M, Han SN, van Calsteren K, Heyns L, Delaere P, Nuyts S, van den Heuvel F, Cheron AC, Fossion E, van den Weyngaert D, Lok C, Amant F, Tongue cancers during pregnancy: Case reports and review of literature. HEAD NECK-J SCI SPEC 2013;35 (4):E102-E108 [PubMed]
Muyldermans K, Moerman P, Amant F, Leunen K, Neven P, Vergote I, Primary invasive mucinous ovarian carcinoma of the intestinal type: Importance of the expansile versus infiltrative type in predicting recurrence and lymph node metastases. EUR J CANCER 2013;49 (7):1600-1608 [PubMed]
Trovik J, Wik E, Werner HMJ, Krakstad C, Helland H, Vandenput I, Njolstad TS, Stefansson IM, Marcickiewicz J, Tingulstad S, Staff AC, Amant F, Akslen LA, Salvesen HB, Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial. EUR J CANCER 2013;49 (16):3431-3441 [PubMed]
van Nieuwenhuysen E, Lambrechts S, Lambrechts D, Leunen K, Amant F, Vergote I, Genetic changes in nonepithelial ovarian cancer. EXPERT REV ANTICANC 2013;13 (7):871-882 [PubMed]
Vergote IB, Chekerov R, Amant F, Harter P, Casado A, Emerich J, Bauknecht T, Mansouri K, Myrand SP, Nguyen TS, Shi P, Sehouli J, Randomized, Phase II, Placebo-Controlled, Double- Blind Study With and Without Enzastaurin in Combination With Paclitaxel and Carboplatin As First-Line Treatment Followed by Maintenance Treatment in Advanced Ovarian Cancer. J CLIN ONCOL 2013;31 (25):3127-+ [PubMed]
Vergote I, du Bois A, Amant F, Heitz F, Leunen K, Harter P, Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?. GYNECOL ONCOL 2013;128 (1):6-11 [PubMed]
Werbrouck J, Bouche G, de Jonge E, Jacomen G, D'Hondt V, Denys H, van Limbergen E, Vandermeersch B, de Schutter H, van Eycken E, Goffin F, Amant F, Evaluation of the quality of the management of cancer of the corpus uteri - Selection of relevant quality indicators and implementation in Belgium. GYNECOL ONCOL 2013;131 (3):512-519 [PubMed]
Werner HMJ, Trovik J, Marcickiewicz J, Tingulstad S, Staff AC, Engh ME, Oddenes K, Rokne JA, Tjugum J, Lode MS, Amant F, Salvesen HB, A discordant histological risk classification in preoperative and operative biopsy in endometrial cancer is reflected in metastatic risk and prognosis. EUR J CANCER 2013;49 (3):625-632 [PubMed]
Zeimet AG, Reimer D, Huszar M, Winterhoff B, Puistola U, Azim SA, Müller-Holzner E, Ben-Arie A, van Kempen LC, Petru E, Jahn S, Geels YP, Massuger LF, Amant F, Polterauer S, Lappi-Blanco E, Bulten J, Meuter A, Tanouye S, Oppelt P, Stroh-Weigert M, Reinthaller A, Mariani A, Hackl W, Netzer M, Schirmer U, Vergote I, Altevogt P, Marth C, Fogel M, L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter Evaluation. JNCI-J NATL CANCER I 2013;105 (15):1142-1150 [PubMed]
Aerts L, Enzlin P, Vergote I, Verhaeghe J, Poppe W, Amant F, Sexual, Psychological, and Relational Functioning in Women after Surgical Treatment for Vulvar Malignancy: A Literature Review. J SEX MED 2012;9 (2):361-371 [PubMed]
Amant F, Safety of chemotherapy in pregnancy. CLIN ADV HEMATOL ONCOL 2012;10 (4):258-259 [PubMed]
Amant F, Han SN, Gziri MM, Dekrem J, van Calsteren K, Chemotherapy during pregnancy. CURR OPIN ONCOL 2012;24 (5):580-586 [PubMed]
Amant F, Loibl S, Neven P, van Calsteren K, Breast cancer in pregnancy. LANCET 2012;379 (9815):570-579 [PubMed]
Amant F, Mirza MR, Creutzberg CL, Cancer of the corpus uteri. INT J GYNECOL OBSTET 2012;119 (2):S110-S117 [PubMed]
Amant F, van Calsteren K, Halaska MJ, Gziri MM, Hui W, Lagae L, Willemsen MA, Kapusta L, van Calster B, Wouters H, Heyns L, Han SN, Tomek V, Mertens L, Ottevanger PB, Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. LANCET ONCOL 2012;13 (3):256-264 [PubMed]
Ameye L, Timmerman D, Valentin L, Paladini D, Zhang J, van Holsbeke C, Lissoni AA, Savelli L, Veldman J, Testa AC, Amant F, van Huffel S, Bourne T, Clinically oriented three-step strategy for assessment of adnexal pathology. ULTRASOUND OBST GYN 2012;40 (5):582-591 [PubMed]
Brouckaert O, Laenen A, Vanderhaegen J, Wildiers H, Leunen K, Amant F, Berteloot P, Smeets A, Paridaens R, Christiaens MR, Floris G, Moerman P, van Limbergen E, Peeters S, Weltens C, Vergote I, Neven P, Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers. ANN ONCOL 2012;23 (10):2578-2584 [PubMed]
Cornelis S, van Calster B, Amant F, Leunen K, van der Zee AGJ, Vergote I, Role of Neoadjuvant Chemotherapy in the Management of Stage IIIC-IV Ovarian Cancer Survey Results from the Members of the European Society of Gynecological Oncology. INT J GYNECOL CANCER 2012;22 (3):407-416 [PubMed]
Deprez S, Amant F, Smeets A, Peeters R, Leemans A, van Hecke W, Verhoeven JS, Christiaens MR, Vandenberghe J, Vandenbulcke M, Sunaert S, Longitudinal Assessment of Chemotherapy-Induced Structural Changes in Cerebral White Matter and Its Correlation With Impaired Cognitive Functioning. J CLIN ONCOL 2012;30 (3):274-281 [PubMed]
Gotlieb WH, Amant F, Advani S, Goswami C, Hirte H, Provencher D, Somani N, Yamada SD, Tamby JF, Vergote I, Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study. LANCET ONCOL 2012;13 (2):154-162 [PubMed]
Gziri MM, Amant F, Debiève F, van Calsteren K, de Catte L, Mertens L, Effects of chemotherapy during pregnancy on the maternal and fetal heart. PRENATAL DIAG 2012;32 (7):614-619 [PubMed]
Gziri MM, Debiève F, de Catte L, Mertens L, Barrea C, van Calsteren K, Han SN, Heyns L, Amant F, Chemotherapy during pregnancy: effect of anthracyclines on fetal and maternal cardiac function. ACTA OBSTET GYN SCAN 2012;91 (12):1465-1468 [PubMed]
Gziri MM, Han SN, Amant F, Use of general anesthesia and sentinel node procedure during pregnancy. J SURG ONCOL 2012;106 (8):1008 [PubMed]
Haest K, Kumar A, van Calster B, Leunen K, Smeets A, Amant F, Berteloot P, Wildiers H, Paridaens R, van Limbergen E, Weltens C, Janssen H, Peeters S, Menten J, Vergote I, Morlion B, Verhaeghe J, Christiaens MR, Neven P, Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-up. ANN ONCOL 2012;23 (6):1449-1454 [PubMed]
Han SN, Amant F, Leunen K, Devi UK, Neven P, Berteloot P, Vergote I, Treatment of high-risk gestational trophoblastic neoplasia with weekly high-dose methotrexate-etoposide. GYNECOL ONCOL 2012;127 (1):47-50 [PubMed]
Han SN, Amant F, Leunen K, Devi UK, Neven P, Vergote I, EP-EMA Regimen (Etoposide and Cisplatin With Etoposide, Methotrexate, and Dactinomycin) in a Series of 18 Women With Gestational Trophoblastic Neoplasia. INT J GYNECOL CANCER 2012;22 (5):875-880 [PubMed]
Han SN, Lotgerink A, Gziri MM, van Calsteren K, Hanssens M, Amant F, Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review. BMC MED 2012;10:86 [PubMed]
Han SN, Vergote I, Amant F, Weekly Paclitaxel/Carboplatin in the Treatment of Locally Advanced, Recurrent, or Metastatic Vulvar Cancer. INT J GYNECOL CANCER 2012;22 (5):865-868 [PubMed]
Kaur M, Joniau S, D'Hoore A, van Calster B, van Limbergen E, Leunen K, Penninckx F, van Poppel H, Amant F, Vergote I, Pelvic Exenterations for Gynecological Malignancies A Study of 36 Cases. INT J GYNECOL CANCER 2012;22 (5):889-896 [PubMed]
Lee CH, Mariño-Enriquez A, Ou W, Zhu M, Ali RH, Chiang S, Amant F, Gilks CB, van de Rijn M, Oliva E, Debiec-Rychter M, Dal Cin P, Fletcher JA, Nucci MR, The Clinicopathologic Features of YWHAE-FAM22 Endometrial Stromal Sarcomas: A Histologically High-grade and Clinically Aggressive Tumor. AM J SURG PATHOL 2012;36 (5):641-653 [PubMed]
Lee CH, Ou WB, Mariño-Enriquez A, Zhu M, Mayeda M, Wang Y, Guo X, Brunner AL, Amant F, French CA, West RB, McAlpine JN, Gilks CB, Yaffe MB, Prentice LM, McPherson A, Jones SJM, Marra MA, Shah SP, van de Rijn M, Huntsman DG, Dal Cin P, Debiec-Rychter M, Nucci MR, Fletcher JA, 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma. P NATL ACAD SCI USA 2012;109 (3):929-934 [PubMed]
Loibl S, Han SN, Amant F, Being Pregnant and Diagnosed with Breast Cancer. BREAST CARE 2012;7 (3):204-209 [PubMed]
Loibl S, Han SN, von Minckwitz G, Bontenbal M, Ring A, Giermek J, Fehm T, van Calsteren K, Linn SC, Schlehe B, Gziri MM, Westenend PJ, Müller V, Heyns L, Rack B, van Calster B, Harbeck N, Lenhard M, Halaska MJ, Kaufmann M, Nekljudova V, Amant F, Treatment of breast cancer during pregnancy: an observational study. LANCET ONCOL 2012;13 (9):887-896 [PubMed]
Long J, Zheng W, Xiang YB, Lose F, Thompson D, Tomlinson I, Yu H, Wentzensen N, Lambrechts D, Dörk T, Dubrowinskaja N, Goodman MT, Salvesen HB, Fasching PA, Scott RJ, Delahanty R, Zheng Y, O'Mara T, Healey CS, Hodgson S, Risch H, Yang HP, Amant F, Turmanov N, Schwake A, Lurie G, Trovik J, Beckmann MW, Ashton K, Ji BT, Bao PP, Howarth K, Lu L, Lissowska J, Coenegrachts L, Kaidarova D, Dürst M, Thompson PJ, Krakstad C, Ekici AB, Otton G, Shi J, Zhang B, Gorman M, Brinton L, Coosemans A, Matsuno RK, Halle MK, Hein A, Proietto A, Cai H, Lu W, Dunning A, Easton D, Gao YT, Cai Q, Spurdle AB, Shu XO, Genome-Wide Association Study Identifies a Possible Susceptibility Locus for Endometrial Cancer. CANCER EPIDEM BIOMAR 2012;21 (6):980-987 [PubMed]
Nijman TAJ, Schutter EM, Amant F, Sentinel node procedure in vulvar carcinoma during pregnancy: A case report. GYNECOL ONCOL CASE REP 2012;2 (2):63-64 [PubMed]
Torfs S, Cadron I, Amant F, Leunen K, Berteloot P, Vergote I, Evaluation of paclitaxel/carboplatin in a dose dense or weekly regimen in 66 patients with recurrent or primary metastatic cervical cancer. EUR J CANCER 2012;48 (9):1332-1340 [PubMed]
van den Bosch T, Coosemans A, Morina M, Timmerman D, Amant F, Screening for uterine tumours. BEST PRACT RES CL OB 2012;26 (2):257-266 [PubMed]
Vandenput I, Vergote I, Neven P, Amant F, Weekly Paclitaxel-Carboplatin Regimen in Patients With Primary Advanced or Recurrent Endometrial Carcinoma. INT J GYNECOL CANCER 2012;22 (4):617-622 [PubMed]
van der Horst PH, Wang Y, Vandenput I, Kühne LC, Ewing PC, van Ijcken WFJ, van der Zee M, Amant F, Burger CW, Blok LJ, Progesterone Inhibits Epithelial-to-Mesenchymal Transition in Endometrial Cancer. PLOS ONE 2012;7 (1):e30840 [PubMed]
van der Zee AGJ, Colombo N, Gitsch G, Reed N, Amant F, Cibula D, Kesic VI, Kimmig R, Lopes ADB, Markowska J, Marth C, Radolakis A, Salvesen H, Vaitkiene D, Verheijen RHM, Zola P, ESGO Statement on the Role of CA/125 Measurement in Follow-Up of Epithelial Ovarian Cancer. INT J GYNECOL CANCER 2012;22 (1):175 [PubMed]
van Gorp T, Veldman J, van Calster B, Cadron I, Leunen K, Amant F, Timmerman D, Vergote I, Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses. EUR J CANCER 2012;48 (11):1649-1656 [PubMed]
Vergote I, Leunen K, Amant F, Primary surgery or neoadjuvant chemotherapy in ovarian cancer: What is the value of comparing apples with oranges?. GYNECOL ONCOL 2012;124 (1):1-2 [PubMed]
Verheijen RHM, Cibula D, Zola P, Reed N [Contributors: van der Zee AGJ, Colombo N, Gitsch G, Reed N, Amant F, Cibula D, Kesic VI, Kimmig R, Lopes ADB, Markowska J, Marth C, Radolakis A, Salvesen H, Vaitkiene D, Verheijen RHM, Zola P]] , Cancer Antigen 125: Lost to Follow-Up? A European Society of Gynaecological Oncology Consensus Statement. INT J GYNECOL CANCER 2012;22 (1):170-174 [PubMed]
Werner HMJ, Trovik J, Marcickiewicz J, Tingulstad S, Staff AC, Amant F, Salvesen HB, Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification. GYNECOL ONCOL 2012;125 (1):103-108 [PubMed]
Amankwah EK, Wang Q, Schildkraut JM, Tsai YY, Ramus SJ, Fridley BL, Beesley J, Johnatty SE, Webb PM, Chenevix-Trench G, Dale LC, Lambrechts D, Amant F, Despierre E, Vergote I, Gayther SA, Gentry-Maharaj A, Menon U, Chang-Claude J, Wang-Gohrke S, Anton-Culver H, Ziogas A, Dörk T, Dürst M, Antonenkova N, Bogdanova N, Brown R, Flanagan JM, Kaye SB, Paul J, Bützow R, Nevanlinna H, Campbell I, Eccles DM, Karlan BY, Gross J, Walsh C, Pharoah PDP, Song H, Krüger Kjær S, Høgdall E, Høgdall C, Lundvall L, Nedergaard L, Kiemeney LALM, Massuger LFAG, van Altena AM, Vermeulen SHHM, Le ND, Brooks-Wilson A, Cook LS, Phelan CM, Cunningham JM, Vachon CM, Vierkant RA, Iversen ES, Berchuck A, Goode EL, Sellers TA, Kelemen LE, Polymorphisms in Stromal Genes and Susceptibility to Serous Epithelial Ovarian Cancer: A Report from the Ovarian Cancer Association Consortium. PLOS ONE 2011;6 (5):e19642 [PubMed]
Amant F, Tousseyn T, Coenegrachts L, Decloedt J, Moerman P, Debiec-Rychter M, Case Report of a Poorly Differentiated Uterine Tumour with t(10;17) Trans location and Neuroectodermal Phenotype. ANTICANCER RES 2011;31 (6):2367-2371 [PubMed]
Boes AS, Tousseyn T, Vandenput I, Timmerman D, Vergote I, Moerman P, Amant F, Pitfall in the diagnosis of endometrial cancer: case report of an endometrioid adenocarcinoma arising from uterine adenomyosis. EUR J GYNAECOL ONCOL 2011;32 (4):431-434 [PubMed]
Cibula D, Verheijen R, Lopes A, Amant F, Beller U, Colombo N, Gitsch G, Kesic V, Kimmig R, Markowska J, Marth C, Reed N, Rodolakis A, Salvesen H, Vaitkiene D, van der Zee AGJ, Zola P, Training in Bowel and Upper Abdominal Surgery in Gynaecological Oncology European Society of Gynecological Oncology (ESGO) Statement. INT J GYNECOL CANCER 2011;21 (7):1264-1265 [PubMed]
Coosemans A, van Calster B, Verbist G, Moerman P, Vergote I, van Gool SW, Amant F, Wilms Tumor Gene 1 (WT1) is a Prognostic Marker in High-Grade Uterine Sarcoma. INT J GYNECOL CANCER 2011;21 (2):302-308 [PubMed]
Deprez S, Amant F, Yigit R, Porke K, Verhoeven J, van den Stock J, Smeets A, Christiaens MR, Leemans A, van Hecke W, Vandenberghe J, Vandenbulcke M, Sunaert S, Chemotherapy-Induced Structural Changes in Cerebral White Matter and its Correlation With Impaired Cognitive Functioning in Breast Cancer Patients. HUM BRAIN MAPP 2011;32 (3):480-493 [PubMed]
Han SN, van Calsteren K, Amant F, Use of chemotherapy during pregnancy in the treatment of ovarian malignancies. EUR J OBSTET GYN R B 2011;156 (2):237 [PubMed]
Hasenburg A, Amant F, Aerts L, Pascal A, Achimas-Cadariu P, Kesic V, Psycho-Oncology Structure and Profiles of European Centers Treating Patients With Gynecological Cancer. INT J GYNECOL CANCER 2011;21 (9):1520-1524 [PubMed]
Healey CS, Ahmed S, O'Mara TA, Ferguson K, Lambrechts D, Garcia-Dios DA, Vergote I, Amant F, Howarth K, Gorman M, Hodgson S, Tomlinson I, Yang HP, Lissowska J, Brinton LA, Chanock S, Garcia-Closas M, Hall P, Liu J, Shah M, Pharoah PDP, Thompson DJ, Rebbeck TR, Strom BL, Dunning AM, Easton DF, Spurdle AB [Contributors: Webb P, Young J, McQuire L, Baron-Hay S, Bell D, Bonaventura A, Brand A, Braye S, Carter J, Chan F, Dalrymple C, Ferrier A, Gard G, Hacker N, Hogg R, Houghton R, Marsden D, McIlroy K, Otton G, Pather S, Proietto A, Robertson G, Scurry J, Sharma R, Wain G, Wong F, Armes J, Crandon A, Cummings M, Land R, Nicklin J, Perrin L, Obermair A, Ward B, Davy M, Dodd T, Miller J, Oehler M, Paramasivum S, Pierides J, Whitehead F, Blomfield P, Challis D, Neesham D, Pyman J, Quinn M, Rome R, Weitzer M, Brennan B, Hammond I, Leung Y, McCartney A, Stewart C, Thompson J, O'Brien S, Moore S, Ferguson K, Walsh M, Cicero R, Green L, Griffith J, Jackman L, Ranieri B, O'Brien M, Schultz P, Alexander B, Baxter C, Croy H, Fitzgerald A, Herron E, Hill C, Jones M, Maidens J, Marshall A, Martin K, Mayhew J, Minehan E, Roffe D, Shirley H, Steane H, Stenlake A, Ward A, Webb S, White J, Despierre E, van Brussel T, Peuteman G, Tomlinson I, Adams M, Al-Samarraie A, Anwar S, Athavale R, Awad S, Bali A, Barnes A, Cawdell G, Chan S, Chin K, Cornes P, Crawford M, Cullimore J, Ghaem-Maghami S, Gornall R, Green J, Hall M, Harvey M, Hawe J, Head A, Herod J, Hingorani M, Hocking M, Holland C, Hollingsworth T, Hollingworth J, Ind T, Irvine R, Irwin C, Katesmark M, Kehoe S, Kheng-Chew G, Lankester K, Linder A, Luesley D, Lynch CB, McFarlane V, Naik R, Nicholas N, Nugent D, Oates S, Oladipo A, Papadopoulos A, Pearson S, Radstone D, Raju S, Rathmell A, Redman C, Rymer M, Sarhanis P, Sparrow G, Stuart N, Sundar S, Thompson A, Tinkler S, Trent S, Tristram A, Walji N, Woolas R, Szeszenia-Dabrowska N, Zatonski W, Chao P, Stagner M, Baynes C, Luccarini C, Conroy D, Harrington P, Mayes R, Munday H, Schinnar R, Weber AL, Bunin G, Berlin JA, Baumgarten M, DeMichele A, Rubin SC, Berlin M, Troxel AB, Turzo E, Burgh D]] , Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study. CARCINOGENESIS 2011;32 (12):1862-1866 [PubMed]
Lai CH, Chao A, Amant F, Vergote I, The 13th Biennial Meeting of the International Gynecologic Cancer Society (IGCS 2010). GYNECOL ONCOL 2011;120 (1):3-4 [PubMed]
Lambrechts S, van Calsteren K, Capoen A, Op de Beeck K, Joniau S, Timmerman D, Amant F, Polypoid endometriosis of the bladder during pregnancy mimicking urachal carcinoma. ULTRASOUND OBST GYN 2011;38 (4):475-478 [PubMed]
O'Mara TA, Fahey P, Ferguson K, Marquart L, Lambrechts D, Despierre E, Vergote I, Amant F, Hall P, Liu J, Czene K, Rebbeck TR, Ahmed S, Dunning AM, Gregory CS, Shah M, Webb PM, Spurdle AB, Progesterone receptor gene variants and risk of endometrial cancer. CARCINOGENESIS 2011;32 (3):331-335 [PubMed]
Pignata S, Amant F, Scambia G, Sorio R, Breda E, Rasch W, Hernes K, Pisano C, Leunen K, Lorusso D, Cannella L, Vergote I, A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy. CANCER CHEMOTH PHARM 2011;68 (5):1347-1353 [PubMed]
Spurdle AB, Thompson DJ, Ahmed S, Ferguson K, Healey CS, O'Mara T, Walker LC, Montgomery SB, Dermitzakis ET, Fahey P, Montgomery GW, Webb PM, Fasching PA, Beckmann MW, Ekici AB, Hein A, Lambrechts D, Coenegrachts L, Vergote I, Amant F, Salvesen HB, Trovik J, Njolstad TS, Helland H, Scott RJ, Ashton K, Proietto T, Otton G, Tomlinson I, Gorman M, Howarth K, Hodgson S, Garcia-Closas M, Wentzensen N, Yang H, Chanock S, Hall P, Czene K, Liu J, Li J, Shu XO, Zheng W, Long J, Xiang YB, Shah M, Morrison J, Michailidou K, Pharoah PD, Dunning AM, Easton DF, Genome-wide association study identifies a common variant associated with risk of endometrial cancer. NAT GENET 2011;43 (5):451-+ [PubMed]
Trovik J, Wik E, Stefansson IM, Marcickiewicz J, Tingulstad S, Staff AC, Njolstad TS, Vandenput I, Amant F, Akslen LA, Salvesen HB [Contributors: Engh ME, Oddenes K, Rokne JA, Jugum JT, Lode MS]] , Stathmin Overexpression Identifies High-Risk Patients and Lymph Node Metastasis in Endometrial Cancer. CLIN CANCER RES 2011;17 (10):3368-3377 [PubMed]
Tsolakidis D, Amant F, Leunen K, Cadron I, Neven P, Vergote I, Comparison of diaphragmatic surgery at primary or interval debulking in advanced ovarian carcinoma: An analysis of 163 patients. EUR J CANCER 2011;47 (2):191-198 [PubMed]
van Calster B, van Ginderachter J, Vlasselaer J, van de Putte G, Berteloot P, Timmerman D, Depypere H, Blomme C, Vlaemynck G, de Jonge E, van den Broecke R, Vergote I, Amant F, van Huffel S, Neven P, Uterine and quality of life changes in postmenopausal women with an asymptomatic tamoxifen-thickened endometrium randomized to continuation of tamoxifen or switching to anastrozole. MENOPAUSE 2011;18 (2):224-229 [PubMed]
van Calsteren K, Amant F, Chemotherapy during pregnancy: pharmacokinetics and impact on foetal neurological development. VERH K ACAD GENEESKD BELG 2011;73 (1-2):105-121 [PubMed]
van Calsteren K, Verbesselt R, van Bree R, Heyns L, de Bruijn E, de Hoon J, Amant F, Substantial Variation in Transplacental Transfer of Chemotherapeutic Agents in a Mouse Model. REPROD SCI 2011;18 (1):57-63 [PubMed]
Vandenput I. Clinicopathologic study in uterine cancer. S.l.: s.n.; 2011. 174p. Proefschrift KU leuven, Faculty of Medicine. (Promotor(s): Amant FCH; copromotor(s): Moerman P)
Vandenput I, Capoen A, Coenegrachts L, Verbist G, Moerman P, Vergote I, Amant F, Expression of ERCC1, p53, and Class III beta-Tubulin Do Not Reveal Chemoresistance in Endometrial Cancer Results From an Immunohistochemical Study. INT J GYNECOL CANCER 2011;21 (6):1071-1077 [PubMed]
Vandenput I, Debiec-Rychter M, Capoen A, Verbist G, Vergote I, Moerman P, Amant F, Kit Gene in Endometrial Carcinoma An Immunohistochemical and Mutational Analysis. INT J GYNECOL CANCER 2011;21 (2):203-205 [PubMed]
Vandenput I, Trovik J, Leunen K, Wik E, Stefansson I, Akslen L, Moerman P, Vergote I, Salvesen H, Amant F, Evolution in Endometrial Cancer Evidence From an Immunohistochemical Study. INT J GYNECOL CANCER 2011;21 (2):316-322 [PubMed]
Vandenput I, Trovik J, Vergote I, Moerman P, Leunen K, Berteloot P, Neven P, Salvesen H, Amant F, The Role of Adjuvant Chemotherapy in Surgical Stages I-II Serous and Clear Cell Carcinomas and Carcinosarcoma of the Endometrium A Collaborative Study. INT J GYNECOL CANCER 2011;21 (2):332-336 [PubMed]
van den Rul N, Han SN, van Calsteren K, Neven P, Amant F, Postpartum breast cancer behaves differently. FACTS VIEWS VIS OBGYN 2011;3 (3):183-188 [PubMed]
Vandorpe T, Smeets A, van Calster B, van Hoorde K, Leunen K, Amant F, Moerman P, Deraedt K, Brouckaert O, van Huffel S, Wildiers H, Christiaens MR, Neven P, Lobular and non-lobular breast cancers differ regarding axillary lymph node metastasis: a cross-sectional study on 4,292 consecutive patients. BREAST CANCER RES TR 2011;128 (2):429-435 [PubMed]
van Gorp T, Cadron I, Despierre E, Daemen A, Leunen K, Amant F, Timmerman D, de Moor B, Vergote I, HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm. BRIT J CANCER 2011;104 (5):863-870 [PubMed]
Vergote I, Amant F, Kristensen G, Ehlen T, Reed NS, Casado A, Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer. EUR J CANCER 2011;47 (3):S88-S92 [PubMed]
Vergote I, Amant F, Timmerman D, Should we screen for endometrial cancer?. LANCET ONCOL 2011;12 (1):4-5 [PubMed]
Vergote I, Tropé CG, Amant F, Ehlen T, Reed NS, Casado A, Neoadjuvant Chemotherapy Is the Better Treatment Option in Some Patients With Stage IIIc to IV Ovarian Cancer. J CLIN ONCOL 2011;29 (31):4076-4078 [PubMed]
Wildiers H, Neven P, Christiaens MR, Squifflet P, Amant F, Weltens C, Smeets A, van Limbergen E, Debrock G, Renard V, van Eenoo L, Wynendaele W, Paridaens R, Neoadjuvant capecitabine and docetaxel (plus trastuzumab): an effective non-anthracycline-based chemotherapy regimen for patients with locally advanced breast cancer. ANN ONCOL 2011;22 (3):588-594 [PubMed]
Amant F, Brepoels L, Halaska MJ, Gziri MM, Calsteren KV, Gynaecologic cancer complicating pregnancy: An overview. BEST PRACT RES CL OB 2010;24 (1):61-79 [PubMed]
Amant F, Deckers S, van Calsteren K, Loibl S, Halaska M, Brepoels L, Beijnen J, Cardoso F, Gentilini O, Lagae L, Mir O, Neven P, Ottevanger N, Pans S, Peccatori F, Rouzier R, Senn HJ, Struikmans H, Christiaens MR, Cameron D, du Bois A, Breast cancer in pregnancy: Recommendations of an international consensus meeting. EUR J CANCER 2010;46 (18):3158-3168 [PubMed]
Amant F, van Calsteren K, Debiec-Rychter M, Heyns L, de Beeck KO, Sagaert X, Bollen B, Vergote I, High-grade endometrial stromal sarcoma presenting in a 28-year-old woman during pregnancy: a case report. J MED CASE REPORTS 2010;4:243 [PubMed]
Amant F, Vergote I, What is the role of neoadjuvant chemotherapy in advanced endometrial cancer?. GYNECOL ONCOL 2010;119 (3):601-601; author reply 602 [PubMed]
Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, van den Berg DJ, Stram DO, Pearce CL, Wu AH, Brewster W, Anton-Culver H, Ziogas A, Narod SA, Levine DA, Kaye SB, Brown R, Paul J, Flanagan J, Sieh W, McGuire V, Whittemore AS, Campbell I, Gore ME, Lissowska J, Yang HP, Medrek K, Gronwald J, Lubinski J, Jakubowska A, Le ND, Cook LS, Kelemen LE, Brooks-Wilson A, Brook-Wilson A, Massuger LFAG, Kiemeney LA, Aben KKH, van Altena AM, Houlston R, Tomlinson I, Palmieri RT, Moorman PG, Schildkraut J, Iversen ES, Phelan C, Vierkant RA, Cunningham JM, Goode EL, Fridley BL, Kruger-Kjaer S, Blaeker J, Hogdall E, Hogdall C, Gross J, Karlan BY, Ness RB, Edwards RP, Odunsi K, Moyisch KB, Baker JA, Modugno F, Heikkinenen T, Butzow R, Nevanlinna H, Leminen A, Bogdanova N, Antonenkova N, Doerk T, Hillemanns P, Dürst M, Runnebaum I, Thompson PJ, Carney ME, Goodman MT, Lurie G, Wang-Gohrke S, Hein R, Chang-Claude J, Rossing MA, Cushing-Haugen KL, Doherty J, Chen C, Rafnar T, Besenbacher S, Sulem P, Stefansson K, Birrer MJ, Terry KL, Hernandez D, Cramer DW, Vergote I, Amant F, Lambrechts D, Despierre E, Fasching PA, Beckmann MW, Thiel FC, Ekici AB, Chen X, Johnatty SE, Webb PM, Beesley J, Chanock S, Garcia-Closas M, Sellers T, Easton DF, Berchuck A, Chenevix-Trench G, Pharoah PDP, Gayther SA, Common variants at 19p13 are associated with susceptibility to ovarian cancer. NAT GENET 2010;42 (10):880-+ [PubMed]
Cadron I, van Gorp T, Mihalyi A, Luyten C, Drijkoningen K, Amant F, Leunen K, Vergote I, The impact of enzastaurin (LY317615.HCl) on CA125 biosynthesis and shedding in ovarian cancer cells. GYNECOL ONCOL 2010;118 (1):64-68 [PubMed]
Coosemans A. Wilms' tumor gene 1 (WT1) as an immunotherapeutic target in uterine cancer. S.l.: s.n.; 2010. 122p. Proefschrift KU Leuven, Faculty of Medicine. (Promotor(s): Amant FCH; copromotor(s): van Gool S)
Coosemans A, Wölfl M, Berneman ZN, van Tendeloo V, Vergote I, Amant F, van Gool SW, Immunological Response after Therapeutic Vaccination with WT1 mRNA-loaded Dendritic Cells in End-stage Endometrial Carcinoma. ANTICANCER RES 2010;30 (9):3709-3714 [PubMed]
Denschlag D, von Wolff M, Amant F, Kesic V, Reed N, Schneider A, Rodolakis A, Clinical Recommendation on Fertility Preservation in Borderline Ovarian Neoplasm: Ovarian Stimulation and Oocyte Retrieval after Conservative Surgery. GYNECOL OBSTET INVES 2010;70 (3):160-165 [PubMed]
Despierre E, Lambrechts D, Neven P, Amant F, Lambrechts S, Vergote I, The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment. GYNECOL ONCOL 2010;117 (2):358-365 [PubMed]
Dierickx I, Jacomen G, Schelfhout V, Moerman P, Corveleyn P, Spiessens T, Amant F, Berteloot P, Primary Retroperitoneal Mucinous Cystadenocarcinoma: A Case Report and Review of the Literature. GYNECOL OBSTET INVES 2010;70 (3):186-191 [PubMed]
Gaudet MM, Yang HP, Bosquet JG, Healey CS, Ahmed S, Dunning AM, Easton DF, Spurdle AB, Ferguson K, O'Mara T, Lambrechts D, Despierre E, Vergote I, Amant F, Lacey JV Jr, Lissowska J, Peplonska B, Brinton LA, Chanock S, Garcia-Closas M, No Association between FTO or HHEX and Endometrial Cancer Risk. CANCER EPIDEM BIOMAR 2010;19 (8):2106-2109 [PubMed]
Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, Lawrenson K, Widschwendter M, Vierkant RA, Larson MC, Kjaer SK, Birrer MJ, Berchuck A, Schildkraut J, Tomlinson I, Kiemeney LA, Cook LS, Gronwald J, Garcia-Closas M, Gore ME, Campbell I, Whittemore AS, Sutphen R, Phelan C, Anton-Culver H, Pearce CL, Lambrechts D, Rossing MA, Chang-Claude J, Moysich KB, Goodman MT, Dörk T, Nevanlinna H, Ness RB, Rafnar T, Hogdall C, Hogdall E, Fridley BL, Cunningham JM, Sieh W, McGuire V, Godwin AK, Cramer DW, Hernandez D, Levine D, Lu K, Iversen ES, Palmieri RT, Houlston R, van Altena AM, Aben KKH, Massuger LFAG, Brooks-Wilson A, Kelemen LE, Le ND, Jakubowska A, Lubinski J, Medrek K, Stafford A, Easton DF, Tyrer J, Bolton KL, Harrington P, Eccles D, Chen A, Molina AN, Davila BN, Arango H, Tsai YY, Chen Z, Risch HA, McLaughlin J, Narod SA, Ziogas A, Brewster W, Gentry-Maharaj A, Menon U, Wu AH, Stram DO, Pike MC, Beesley J, Webb PM, Chen X, Ekici AB, Thiel FC, Beckmann MW, Yang H, Wentzensen N, Lissowska J, Fasching PA, Despierre E, Amant F, Vergote I, Doherty J, Hein R, Wang-Gohrke S, Lurie G, Carney ME, Thompson PJ, Runnebaum I, Hillemanns P, Dürst M, Antonenkova N, Bogdanova N, Leminen A, Butzow R, Heikkinen T, Stefansson K, Sulem P, Besenbacher S, Sellers TA, Gayther SA, Pharoah PDP, A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. NAT GENET 2010;42 (10):874-+ [PubMed]
Han SN, van Calsteren K, Heyns L, Mhallem Gziri M, Amant F, Breast cancer during pregnancy: a literature review. MINERVA GINECOL 2010;62 (6):585-597 [PubMed]
Kesic V, Rodolakis A, Denschlag D, Schneider A, Morice P, Amant F, Reed N, Fertility Preserving Management in Gynecologic Cancer Patients The Need for Centralization. INT J GYNECOL CANCER 2010;20 (9):1613-1617 [PubMed]
Testelmans D, van Raemdonck D, Amant F, de Wever W, Verbeken E, Nackaerts K, LATE RECURRENT OVARIAN CARCINOMA METASTATIC TO THE THORACIC WALL. ACTA CLIN BELG 2010;65 (5):354-356 [PubMed]
Tsolakidis D, Amant F, van Gorp T, Leunen K, Neven P, Vergote I, Diaphragmatic surgery during primary debulking in 89 patients with stage IIIB-IV epithelial ovarian cancer. GYNECOL ONCOL 2010;116 (3):489-496 [PubMed]
Tsolakidis D, Amant F, van Gorp T, Leunen K, Neven P, Vergote I, The Role of Diaphragmatic Surgery During Interval Debulking After Neoadjuvant Chemotherapy An Analysis of 74 Patients With Advanced Epithelial Ovarian Cancer. INT J GYNECOL CANCER 2010;20 (4):542-551 [PubMed]
van Belle V, van Calster B, Brouckaert O, Vanden Bempt I, Pintens S, Harvey V, Murray P, Naume B, Wiedswang G, Paridaens R, Moerman P, Amant F, Leunen K, Smeets A, Drijkoningen M, Wildiers H, Christiaens MR, Vergote I, van Huffel S, Neven P, Qualitative Assessment of the Progesterone Receptor and HER2 Improves the Nottingham Prognostic Index Up to 5 Years After Breast Cancer Diagnosis. J CLIN ONCOL 2010;28 (27):4129-4134 [PubMed]
van Calsteren K, Heyns L, de Smet F, van Eycken L, Gziri MM, van Gemert W, Halaska M, Vergote I, Ottevanger N, Amant F, Cancer During Pregnancy: An Analysis of 215 Patients Emphasizing the Obstetrical and the Neonatal Outcomes. J CLIN ONCOL 2010;28 (4):683-689 [PubMed]
van Calsteren K, Verbesselt R, Beijnen J, Devlieger R, de Catte L, Chai DC, van Bree R, Heyns L, de Hoon J, Amant F, Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model. GYNECOL ONCOL 2010;119 (3):594-600 [PubMed]
van Calsteren K, Verbesselt R, Devlieger R, de Catte L, Chai DC, van Bree R, Heyns L, Beijnen J, Demarsin S, de Bruijn E, de Hoon J, Amant F, Transplacental Transfer of Paclitaxel, Docetaxel, Carboplatin, and Trastuzumab in a Baboon Model. INT J GYNECOL CANCER 2010;20 (9):1456-1464 [PubMed]
van Calsteren K, Verbesselt R, Ottevanger N, Halaska M, Heyns L, van Bree R, de Bruijn E, Chai D, Delforge M, Noens L, Renard V, Witteveen E, Rob L, de Hoon J, Amant F, Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study. ACTA OBSTET GYN SCAN 2010;89 (10):1338-1345 [PubMed]
Vandenbriele C, Dierickx D, Amant F, Delforge M, The treatment of hematologic malignancies in pregnancy. FACTS VIEWS VIS OBGYN 2010;2 (2):74-87 [PubMed]
Vandenput I, Vanhove T, Calster BV, Gorp TV, Moerman P, Verbist G, Vergote I, Amant F, The Use of Lymph Vessel Markers to Predict Endometrial Cancer Outcome. INT J GYNECOL CANCER 2010;20 (3):363-367 [PubMed]
Vergote I, Amant F, Leunen K, Neoadjuvant chemotherapy in advanced ovarian cancer: What kind of evidence is needed to convince US gynaecological oncologists?. GYNECOL ONCOL 2010;119 (1):1-2 [PubMed]
Vergote I, Amant F, Neven P, Laparoscopic hysterectomy for early endometrial cancer. LANCET ONCOL 2010;11 (8):707-708 [PubMed]
Vergote I, Tropé CG, Amant F, Kristensen GB, Ehlen T, Johnson N, Verheijen RHM, van der Burg MEL, Lacave AJ, Panici PB, Kenter GG, Casado A, Mendiola C, Coens C, Verleye L, Stuart GCE, Pecorelli S, Reed NS [Contributors: Angioli R, Bentley J, Berteloot P, Bessette P, Boman K, Buist M, Chan K, Chan S, Coronado Martín P, Counsell R, Cruickshank DJ, Davis J, de Greve J, de Oliveira CF, de Valk B, Dittrich C, Elit L, Favalli G, Floquet A, Gauthier P, Gerdin E, Ghatage P, Gilby E, Gleeson N, Gotlieb W, Green JA, Grimshaw R, Heywood M, Hirsch V, Hoekman K, Honkoop A, Hoskins P, Kannisto P, Kaern J, Katsaros D, Kieser K, Kristeller TV, Leblanc E, Ledermann J, Leunen K, Lotocki R, Maggino T, Marth C, Martin L, Massuger L, Miller D, Mosgaard B, Mota F, Neven P, Nooij M, Nordal R, Nordin A, Ottevanger PB, Papadopoulos A, Petru E, Plante M, Popadiuk C, Provencher D, Redman C, Roozendaal KJ, Rustin G, Sadozye AH, Sandvei R, Seoane JM, Sereni MI, Sert B, Siddiqui N, Speiser P, Tholander B, Tognon G, Trimbos B, Trudeau M, van Baal M, van Doorn HC, van der Velden J, van Eygen K, Vermorken JB, Vidart Aragon JA, Wensveen CWM, Zola P, Anastosopoulou A, Bethe U, Dehaes K, Demeester A, Demonty G, de Heusch E, de Rouck M, Giurgea L, Hoctin-Boes G, Teodorovic I, Ven K, van Luijk I, Bacon M, Eisenhauer E]] , Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. NEW ENGL J MED 2010;363 (10):943-953 [PubMed]
Aerts L, Enzlin P, Verhaeghe J, Vergote I, Amant F, Sexual and psychological functioning in women after pelvic surgery for gynaecological cancer. EUR J GYNAECOL ONCOL 2009;30 (6):652-656 [PubMed]
Amant F, Coosemans A, Debiec-Rychter M, Timmerman D, Vergote I, Clinical management of uterine sarcomas. LANCET ONCOL 2009;10 (12):1188-1198 [PubMed]
Amant F, Coosemans A, Renard V, Everaert E, Vergote I, Clinical Outcome of ET-743 (Trabectedin; Yondelis) in High-Grade Uterine Sarcomas Report on Five Patients and a Review of the Literature. INT J GYNECOL CANCER 2009;19 (2):245-248 [PubMed]
Amant F, Despierre E, Vandenput I, Residual tumor after neoadjuvant chemotherapy and interval debulking surgery for advanced endometrial cancer. GYNECOL ONCOL 2009;114 (2):370 [PubMed]
Amant F, Neven P, Vergote I, Lymphadenectomy in endometrial cancer. LANCET 2009;373 (9670):1169-1170 [PubMed]
Amant F, van Calsteren K, Halaska MJ, Beijnen J, Lagae L, Hanssens M, Heyns L, Lannoo L, Ottevanger NP, Vanden Bogaert W, Ungar L, Vergote I, du Bois A, Gynecologic Cancers in Pregnancy: Guidelines of an International Consensus Meeting. INT J GYNECOL CANCER 2009;19 (1):S1-S12 [PubMed]
Brouckaert O, Pintens S, van Belle V, van Huffel S, Camerlynck E, Amant F, Leunen K, Smeets A, Berteloot P, van Limbergen E, Decock J, Hendrickx W, Weltens C, van den Bogaert W, Vanden Bempt I, Drijkoningen M, Paridaens R, Wildiers H, Vergote I, Christiaens MR, Neven P, Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors. BREAST CANCER RES TR 2009;115 (2):349-358 [PubMed]
Cadron I, van Gorp T, Amant F, Vergote I, Moerman P, Waelkens E, Daemen A, van de Plas R, de Moor B, Zeillinger R, The Use of Laser Microdissection and SELDI-TOF MS in Ovarian Cancer Tissue to Identify Protein Profiles. ANTICANCER RES 2009;29 (4):1039-1045 [PubMed]
Cadron I, van Gorp T, Timmerman D, Amant F, Waelkens E, Vergote I, Application of proteomics in ovarian cancer: Which sample should be used?. GYNECOL ONCOL 2009;115 (3):497-503 [PubMed]
Coosemans A, Moerman P, Vergote I, Koninckx PR, van Gool SW, Amant F, Wilms' tumor gene 1 (WT1) overexpression in neurons in deep endometriosis: a pilot study. FERTIL STERIL 2009;91 (4):1441-1444 [PubMed]
Coosemans A, van Hove T, Verbist G, Moons L, Neven P, Moerman P, Vergote I, van Gool SW, Amant F, Wilms' tumour gene 1 (WT1) positivity in endothelial cells surrounding epithelial uterine tumours. HISTOPATHOLOGY 2009;54 (3):384-387 [PubMed]
Deckers S, Amant F, Breast cancer in pregnancy: a literature review. FACTS VIEWS VIS OBGYN 2009;1 (2):130-141 [PubMed]
Dieudonné AS, Lambrechts D, Claes B, Vandorpe T, Wildiers H, Timmerman D, Billen J, Leunen K, Amant F, Berteloot P, Smeets A, Paridaens R, Weltens C, van Limbergen E, van den Bogaert W, Vergote I, van Huffel S, Christiaens MR, Neven P, Prevalent breast cancer patients with a homozygous mutant status for CYP2D6*4: response and biomarkers in tamoxifen users. BREAST CANCER RES TR 2009;118 (3):531-538 [PubMed]
Kitchener HC, Trimble EL [Contributors: Altgassen C, Aghajanian C, Amant F, Birrer M, Blake P, Boyd J, Brady M, Cantu D, Cibull M, Copeland L, Creasman W, Creutzberg C, Darcy K, Davidson S, DiSaia P, Filiaci G, Fleming G, Gabra H, Gaffney D, Goldman P, Goodfellow P, Green J, Hall G, Hawnaur J, Hogberg T, Holland C, Hoskins W, Linsey J, Jhingran A, Kang S, Kehoe S, Kim JW, Kitchener H, Konishi I, Kristensen G, Ledermann J, Leslie K, Lively T, Livsey J, Lu K, Marth C, Mathias L, McCluggage G, McConnell D, McMeekin S, Maxwell L, Miller D, Mundt A, Mutter G, Orton J, Oza A, Perren T, Petryshun R, Pignata S, Podratz K, Powell M, Randall M, Reed N, Sagae S, Salvesen H, Sehouli J, Klinikum V, Sheridan E, Slomovitz B, Small W, Stuart G, Swart AM, Symonds P, Tay SK, Thigpen JT, Thomas G, Tominson I, Tongaonkar H, Trimble E, Walker J, Wong YF]] , Endometrial Cancer State of the Science Meeting. INT J GYNECOL CANCER 2009;19 (1):134-140 [PubMed]
Leunen K, Cadron I, van Gorp T, Amant F, Berteloot P, Neven P, Legius E, Vergote I, Does Paclitaxel-Carboplatin Chemotherapy in a Dose-Dense Regimen Enhance Survival of BRCA-Related Ovarian Cancer Patients?. INT J GYNECOL CANCER 2009;19 (9):1501-1504 [PubMed]
Mispelaere B, van de Werf E, D'Hooghe T, Dieudonné AS, Amant F, van Mieghem T, Neven P, Paridaens R, Wildiers H, Reproduction Rates After Cytotoxic Therapy. J CLIN ONCOL 2009;27 (27):E118-E119 [PubMed]
Neven P, Amant F, Poppe W, van den Broecke R, Levonorgestrel-releasing intra-uterine systems (LNG-IUS) and breast cancer. FERTIL STERIL 2009;91 (4):E5 [PubMed]
van Calster B, Vanden Bempt I, Drijkoningen M, Pochet N, Cheng J, van Huffel S, Hendrickx W, Decock J, Huang HJ, Leunen K, Amant F, Berteloot P, Paridaens R, Wildiers H, van Limbergen E, Weltens C, Timmerman D, van Gorp T, Smeets A, van den Bogaert W, Vergote I, Christiaens MR, Neven P, Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive. BREAST CANCER RES TR 2009;113 (1):181-187 [PubMed]
van Calsteren K. Chemotherapy during Pregnancy: Pharmacokinetics and Impact on Foetal Neurological Development. S.l.: s.n.; 2009. 212p. Proefschrift KU Leuven, Faculty of Medicine. (Promotor(s): Amant FCH; copromotor(s): Ottevanger N)
van Calsteren K, de Catte L, Devlieger R, Chai DC, Amant F, Sonographic biometrical normograms and estimation of fetal weight in the baboon (Papio anubis). J MED PRIMATOL 2009;38 (5):321-327 [PubMed]
van Calsteren K, Devlieger R, de Catte L, D'Hooghe T, Chai DC, Mwenda JM, Vergote I, Amant F, Feasibility of Ultrasound-guided Percutaneous Samplings in the Pregnant Baboon: A Model for Studies on Transplacental Transport. REPROD SCI 2009;16 (3):280-285 [PubMed]
van Calsteren K, Hartmann D, van Aerschot L, Verbesselt R, van Bree R, D'Hooge R, Amant F, Vinblastine and doxorubicin administration to pregnant mice affects brain development and behaviour in the offspring. NEUROTOXICOLOGY 2009;30 (4):647-657 [PubMed]
Vandenput I, van Calster B, Capoen A, Leunen K, Berteloot P, Neven P, Moerman P, Vergote I, Amant F, Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?. BRIT J CANCER 2009;101 (2):244-249 [PubMed]
Vandenput I, van Eygen K, Moerman P, Vergote I, Amant F, Ineffective attempt to preserve fertility with a levonorgestrel-releasing intrauterine device in a young woman with endometrioid endometrial carcinoma: a case report and review of the literature. EUR J GYNAECOL ONCOL 2009;30 (3):313-316 [PubMed]
Vandenput I, Vergote I, Leunen K, Berteloot P, Neven P, Amant F, Leuven Dose-Dense Paclitaxel/Carboplatin Regimen in Patients With Primary Advanced or Recurrent Endometrial Carcinoma. INT J GYNECOL CANCER 2009;19 (6):1147-1151 [PubMed]
van Holsbeke C, Amant F, Veldman J, de Boodt A, Moerman P, Timmerman D, Picture of the Month Hyperreactio luteinalis in a spontaneously conceived singleton pregnancy. ULTRASOUND OBST GYN 2009;33 (3):371-373 [PubMed]
Vergote I, Amant F, Ameye L, Timmerman D, Screening for ovarian carcinoma: not quite there yet. LANCET ONCOL 2009;10 (4):308-309 [PubMed]
Vergote I, Amant F, Neven P, Is It Safe to Treat Endometrial Carcinoma Endoscopically?. J CLIN ONCOL 2009;27 (32):5305-5307 [PubMed]
Vergote I, Amant F, Oskay-Oezcelik G, Musib L, Michel AL, Darstein C, Kania M, Bauknecht T, Sehouli J, Carboplatin and Paclitaxel in Combination With Oral Enzastaurin in Advanced Ovarian or Primary Peritoneal Cancer Results From a Safety Lead-in Study. INT J GYNECOL CANCER 2009;19 (9):1505-1510 [PubMed]
Vergote I, Amant F, van Gorp T, Role of Diaphragmatic Surgery in 69 Patients With Ovarian Carcinoma. INT J GYNECOL CANCER 2009;19 (3):481 [PubMed]
Wildiers H, Dirix L, Neven P, Prové A, Clement P, Squifflet P, Amant F, Skacel T, Paridaens R, Delivery of adjuvant sequential dose-dense FEC-Doc to patients with breast cancer is feasible, but dose reductions and toxicity are dependent on treatment sequence. BREAST CANCER RES TR 2009;114 (1):103-112 [PubMed]
Amant F, van Calsteren K, Vergote I, Ottevanger N, Gynecologic oncology in pregnancy. CRIT REV ONCOL HEMAT 2008;67 (3):187-195 [PubMed]
Chia S, Gradishar W, Mauriac L, Bines J, Amant F, Federico M, Fein L, Romieu G, Buzdar A, Robertson JFR, Brufsky A, Possinger K, Rennie P, Sapunar F, Lowe E, Piccart M, Double-blind, Randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: Results from EFECT. J CLIN ONCOL 2008;26 (10):1664-1670 [PubMed]
Coosemans A, Moerman P, Verbist G, Maes W, Neven P, Vergote I, van Gool SW, Amant F, Wilms' tumor gene 1 (WT1) in endometrial carcinoma. GYNECOL ONCOL 2008;111 (3):502-508 [PubMed]
de Maeyer L, van Limbergen E, de Nys K, Moerman P, Pochet N, Hendrickx W, Wildiers H, Paridaens R, Smeets A, Christiaens MR, Vergote I, Leunen K, Amant F, Neven P, Does estrogen receptor-negative/progesterone receptor-positive breast carcinoma exist?. J CLIN ONCOL 2008;26 (2):335-336 [PubMed]
Devolder K, Amant F, Neven P, van Gorp T, Leunen K, Vergote I, Role of diaphragmatic surgery in 69 patients with ovarian carcinoma. INT J GYNECOL CANCER 2008;18 (2):363-368 [PubMed]
Gevaert O, de Smet F, van Gorp T, Pochet N, Engelen K, Amant F, de Moor B, Timmerman D, Vergote I, Expression profiling to predict the clinical behaviour of ovarian cancer fails independent evaluation. BMC CANCER 2008;8:18 [PubMed]
Leunen K, Drijkoningen M, Neven P, Christiaens MR, van Ongeval C, Legius E, Amant F, Berteloot P, Vergote I, Prophylactic mastectomy in familial breast carcinoma. What do the pathologic findings learn us?. BREAST CANCER RES TR 2008;107 (1):79-86 [PubMed]
Mortier DG, Stroobants S, Amant F, Neven P, van Limbergen E, Vergote I, Laparoscopic para-aortic lymphadenectomy and positron emission tomography scan as staging procedures in patients with cervical carcinoma stage IB2-IIIB. INT J GYNECOL CANCER 2008;18 (4):723-729 [PubMed]
Mota F, Vergote I, Trimbos JB, Amant F, Siddiqui N, del Rio A, Verheijen R, Zola P, Classification of radical hysterectomy adopted by the Gynecological Cancer Group of the European Organization for Research and Treatment of Cancer. INT J GYNECOL CANCER 2008;18 (5):1136-1138 [PubMed]
Neven P, Brouckaert O, van Belle V, Vanden Bempt I, Hendrickx W, Cho H, Deraedt K, van Calster B, van Huffel S, Moerman P, Amant F, Leunen K, Smeets A, Wildiers H, Paridaens R, Vergote I, Christiaens MR, In early-stage breast cancer, the estrogen receptor interacts with correlation between human epidermal growth factor receptor 2 status and age at diagnosis, tumor grade, and lymph node involvement. J CLIN ONCOL 2008;26 (10):1768-1769 [PubMed]
Neven P, van Calster B, van den Bempt I, van Huffel S, van Belle V, Hendrickx W, Decock J, Wildiers H, Paridaens R, Amant F, Leunen K, Berteloot P, Timmerman D, van Limbergen E, Weltens C, van den Bogaert W, Smeets A, Vergote I, Christiaens MR, Drijkoningen M, Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer. BREAST CANCER RES TR 2008;110 (1):153-159 [PubMed]
van Calsteren K, Hanssens M, Moerman P, Orye G, Bielen D, Vergote I, Amant F, Successful conservative treatment of endocervical adenocarcinoma stage Ib1 diagnosed early in pregnancy. ACTA OBSTET GYN SCAN 2008;87 (2):250-253 [PubMed]
Vandenhove M, Amant F, van Schoubroeck D, Cannie M, Dymarkowski S, Hanssens M, Complete hydatidiform mole with co-existing healthy fetus: A case report. J MATERN-FETAL NEO M 2008;21 (5):341-344 [PubMed]
Vandenput I, Vanden Bempt I, Leunen K, Neven P, Berteloot P, Moerman P, Vergote I, Amant F, Limited Clinical Benefit from Trastuzumab in Recurrent Endometrial Cancer Two Case Reports. GYNECOL OBSTET INVES 2008;67 (1):46-48 [PubMed]
van Keirsbilck J, Riphagen I, Struyven H, van den Eeckhout A, Cornelis A, Neven P, Amant F, Vergote I, Bilateral mammary tuberculosis associated with a borderline ovarian tumor. BREAST CARE 2008;3 (3):200-203 [PubMed]
Vergote I, Amant F, Leunen K, Cadron I, van Gorp T, Neven P, Berteloot P, Intraperitoneal chemotherapy in patients with advanced ovarian cancer: The con view. ONCOLOGIST 2008;13 (4):410-414 [PubMed]
Vergote I, Pouseele B, van Gorp T, Vanacker B, Leunen K, Cadron I, Neven P, Amant F, Robotic retroperitoneal lower para-aortic lymphadenectomy in cervical carcinoma: First report on the technique used in 5 patients. ACTA OBSTET GYN SCAN 2008;87 (7):783-787 [PubMed]
Vergote I, Tsolakidis D, Mortier D, Neven P, Amant F, Mottaghy F, van Limbergen E, Value of Positron Emission Tomography of the Para-Aortic Lymph Nodes in Cervical Carcinoma Stage IB2-IIIB. J CLIN ONCOL 2008;26 (34):5654-U186 [PubMed]
Vergote I, van Gorp T, Amant F, Leunen K, Neven P, Berteloot P, Timing of debulking surgery in advanced ovarian cancer. INT J GYNECOL CANCER 2008;18 (1):11-19 [PubMed]
Verguts J, Vergote I, Amant F, Moerman P, Koninckx P, The Addition of 4% Oxygen to the CO2 Pneumoperitoneum Does Not Decrease Dramatically Port Site Metastases. J MINIM INVAS GYN 2008;15 (6):700-703 [PubMed]
Amant F, de Knijf A, van Calster B, Leunen K, Neven P, Berteloot P, Vergote I, van Huffel S, Moerman P, Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma. BRIT J CANCER 2007;97 (9):1194-1199 [PubMed]
Amant F, Moerman P, Neven P, Timmerman D, van Limbergen E, Vergote I, Treatment modalities in endometrial cancer. CURR OPIN ONCOL 2007;19 (5):479-485 [PubMed]
Cadron I, Leunen K, Amant F, van Gorp T, Neven P, Vergote I, The "Leuven" dose-dense paclitaxel/carboplatin regimen in patients with recurrent ovarian cancer. GYNECOL ONCOL 2007;106 (2):354-361 [PubMed]
Cadron I, Leunen K, van Gorp T, Amant F, Neven P, Vergote I, Management of borderline ovarian neoplasms. J CLIN ONCOL 2007;25 (20):2928-2937 [PubMed]
Cadron I, van Gorp T, Amant F, Leunen K, Neven P, Vergote I, Chemotherapy for recurrent cervical cancer. GYNECOL ONCOL 2007;107 (1 Suppl 1):S113-S118 [PubMed]
Coosemans A, Nik SA, Caluwaerts S, Lambin S, Verbist G, van Bree R, Schelfhout V, de Jonge E, Dalle I, Jacomen G, Cassiman JJ, Moerman P, Vergote I, Amant F, Upregulation of Wilms' tumour gene 1 (WT1) in uterine sarcomas. EUR J CANCER 2007;43 (10):1630-1637 [PubMed]
Kalogiannidis I, Lambrechts S, Amant F, Neven P, van Gorp T, Vergote I, Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome. AM J OBSTET GYNECOL 2007;196 (3):248.e1-248.e8 [PubMed]
Lannoo L, Smets S, Steenkiste E, Delforge M, Moerman P, Stroobants S, Knockaert D, Amant F, Intravascular large B-cell lymphoma of the uterus presenting as fever of unknown origin (FUO) and revealed by FDG-PET. ACTA CLIN BELG 2007;62 (3):187-190 [PubMed]
Morales L, Pans S, Paridaens R, Westhovens R, Timmerman D, Verhaeghe J, Wildiers H, Leunen K, Amant F, Berteloot P, Smeets A, van Limbergen E, Weltens C, van den Bogaert W, de Smet L, Vergote I, Christiaens MR, Neven P, Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging. BREAST CANCER RES TR 2007;104 (1):87-91 [PubMed]
van Calster B, Timmerman D, Lu C, Suykens JAK, Valentin L, van Holsbeke C, Amant F, Vergote I, van Huffel S, Preoperative diagnosis of ovarian tumors using Bayesian kernel-based methods. ULTRASOUND OBST GYN 2007;29 (5):496-504 [PubMed]
van den Bosch T, van Schoubroeck D, Domali E, Vergote I, Moerman P, Amant F, Timmerman D, A thin and regular endometrium on ultrasound is very unlikely in patients with endometrial malignancy. ULTRASOUND OBST GYN 2007;29 (6):674-679 [PubMed]
Vandenput I, Amant F, Neven P, Berteloot P, Leunen K, Vergote I, Effectiveness of weekly topotecan in patients with recurrent epithelial ovarian cancer. INT J GYNECOL CANCER 2007;17 (1):83-87 [PubMed]
van Gorp T, Amant F, Neven P, Berteloot P, Leunen K, Vergote I, The role of neoadjuvant chemotherapy versus primary surgery in the management of stage III ovarian cancer. CANCER TREAT RES 2007;134:387-402 [PubMed]
van Mieghem T, Leunen K, Pochet N, de Moor B, de Smet F, Amant F, Berteloot P, Timmerman D, Vanden Bempt I, Drijkoningen R, Wildiers H, Paridaens R, Smeets A, Hendrickx W, van Limbergen E, Christiaens MR, Vergote I, Neven P, Body mass index and HER-2 overexpression in breast cancer patients over 50 years of age. BREAST CANCER RES TR 2007;106 (1):127-133 [PubMed]
Verguts J, Amant F, Moerman P, Vergote I, HPV induced ovarian squamous cell carcinoma: case report and review of the literature. ARCH GYNECOL OBSTET 2007;276 (3):285-289 [PubMed]
Amant F, Leunen K, Neven P, Berteloot P, Vergote I, Endometrial cancer: predictors of response and preferred endocrine therapy. INT J GYNECOL CANCER 2006;16 (Suppl. 2):527-528 [PubMed]
Amant F, Vandenput I, van Gorp T, Vergote I, Moerman P, Endometrial carcinosarcoma with osteoclast-like giant cells. EUR J GYNAECOL ONCOL 2006;27 (1):92-94 [PubMed]
Amant F, Woestenborghs H, Vandenbroucke V, Berteloot P, Neven P, Moerman P, Vergote I, Transition of endometrial stromal sarcoma into high-grade sarcoma. GYNECOL ONCOL 2006;103 (3):1137-1140 [PubMed]
Bergeron C, Amant F, Ferenczy A, Pathology and physiopathology of adenomyosis. BEST PRACT RES CL OB 2006;20 (4):511-521 [PubMed]
Cadron I, Amant F, van Gorp T, Neven P, Leunen K, Vergote I, The management of borderline tumours of the ovary. CURR OPIN ONCOL 2006;18 (5):488-493 [PubMed]
Caluwaerts S, van Calsteren K, Mertens L, Lagae L, Moerman P, Hanssens M, Wuyts K, Vergote I, Amant F, Neoadjuvant chemotherapy followed by radical hysterectomy for invasive cervical cancer diagnosed during pregnancy: report of a case and review of the literature. INT J GYNECOL CANCER 2006;16 (2):905-908 [PubMed]
Colombo N, van Gorp T, Parma G, Amant F, Gatta G, Sessa C, Vergote I, Ovarian cancer. CRIT REV ONCOL HEMAT 2006;60 (2):159-179 [PubMed]
de Smet F, de Brabanter J, van den Bosch T, Pochet N, Amant F, van Holsbeke C, Moerman P, de Moor B, Vergote I, Timmerman D, New models to predict depth of infiltration in endometrial carcinoma based on transvaginal sonography. ULTRASOUND OBST GYN 2006;27 (6):664-671 [PubMed]
de Smet F, Pochet NLMM, Engelen K, van Gorp T, van Hummelen P, Marchal K, Amant F, Timmerman D, de Moor BLR, Vergote IB, Predicting the clinical behavior of ovarian cancer from gene expression profiles. INT J GYNECOL CANCER 2006;16 (Suppl. 1):147-151 [PubMed]
Despierre E, Moerman P, Vergote I, Amant F, Is there a role for neoadjuvant chemotherapy in the treatment of stage IV serous endometrial carcinoma?. INT J GYNECOL CANCER 2006;16 (Suppl. 1):273-277 [PubMed]
Fuso L, Amant F, Neven P, Berteloot P, Vergote I, Gemcitabine-carboplatin-paclitaxel combination as first-line therapy in advanced ovarian carcinoma: a single institution phase II study in 24 patients. INT J GYNECOL CANCER 2006;16 (Suppl. 1):60-67 [PubMed]
Gevaert O, Pochet N, de Smet F, van Gorp T, de Moor B, Timmerman D, Amant F, Vergote I, Molecular profiling of platinum resistant ovarian cancer: use of the model in clinical practice. INT J CANCER 2006;119 (6):1511; author reply 1512 [PubMed]
Kalogiannidis I, Lambrechts S, Amant F, Neven P, van Limbergen E, Vergote I, Role of lymphadenectomy and pelvic radiotherapy in patients with clinical FIGO stage I endometrial adenocarcinoma: An analysis of 208 patients. INT J GYNECOL CANCER 2006;16 (5):1885-1893 [PubMed]
Leunen K, LEGIUS E, Moerman P, Amant F, Neven P, Vergote I, Prophylactic salpingo-oophorectomy in 51 women with familial breast-ovarian cancer: importance of fallopian tube dysplasia. INT J GYNECOL CANCER 2006;16 (1):183-188 [PubMed]
Marquette A, Moerman P, Vergote I, Amant F, Second case of uterine mesonephric adenocarcinoma. INT J GYNECOL CANCER 2006;16 (3):1450-1454 [PubMed]
Marquette S, Amant F, Vergote I, Moerman P, Pseudomyxoma peritonei associated with a mucinous ovarian tumor arising from a mature cystic teratoma. A case report. INT J GYNECOL PATHOL 2006;25 (4):340-343 [PubMed]
Neven P, Paridaens R, Amant F, Wildiers H, Berteloot P, Leunen K, Smeets A, Weltens C, van den Bogaert W, van Limbergen E, Christiaens MR, Vergote I, Adjuvant therapy for postmenopausal ER-positive breast cancer. Why tamoxifen still has a future? The Leuven point of view. INT J GYNECOL CANCER 2006;16 (Suppl. 2):505-510 [PubMed]
Neven P, Pochet N, Drijkoningen M, Amant F, de Smet F, Paridaens R, Christiaens MR, Vergote I, Progesterone receptor in estrogen receptor-positive breast cancer: the association between HER-2 and lymph node involvement is age related. J CLIN ONCOL 2006;24 (16):2595; author reply 2595-2595; author reply 2597 [PubMed]
Neven P, Vergote I, Amant F, Berteloot P, de Jonge E, de Rop C, de Sutter P, Makar A, van Ginderachter J, Endocrine Treatment and Prevention of Breast and Gynecological Cancers Vth International Symposium of the Flemish Gynecological Oncology Group, January 26-28, 2006. INT J GYNECOL CANCER 2006;16 (Suppl. 2):479-491 [PubMed]
van Calsteren K, Berteloot P, Hanssens M, Vergote I, Amant F, Ganame J, Claus P, Mertens L, Lagae L, Delforge M, Paridaens R, Noens L, Humblet Y, Vandermeersch B, de Muylder X, In utero exposure to chemotherapy: effect on cardiac and neurologic outcome. J CLIN ONCOL 2006;24 (12):e16-e17 [PubMed]
van Calsteren K, van Mensel K, Joniau S, Oyen R, Hanssens M, Amant F, van Poppel H, Urachal carcinoma during pregnancy. UROLOGY 2006;67 (6):1290.e19-1290.e21 [PubMed]
Vandenbroucke V, Moerman P, Amant F, Laparoscopy and peritoneal tuberculosis. INT J GYNECOL OBSTET 2006;95 (1):58-59 [PubMed]
Vandenput I, Vergote I, Amant F, Neven P, Paridaens R, Christiaens MR, Aromatase inhibitors in premenopausal women: the need for proper contraceptive counseling. BREAST J 2006;12 (5):507-508 [PubMed]
van Gorp T, Amant F, Neven P, Berteloot P, Leunen K, Vergote I, The position of neoadjuvant chemotherapy within the treatment of ovarian cancer. MINERVA GINECOL 2006;58 (5):393-403 [PubMed]
van Gorp T, Vergote IB, Pochet NLMM, Amant F, Methodology in plasma proteomic pattern experiments. INT J GYNECOL CANCER 2006;16 (5):1951-2; author reply 1953 [PubMed]
Vergote I, Amant F, Time to include high-risk early ovarian cancer in randomized phase III trials of advanced ovarian cancer. GYNECOL ONCOL 2006;102 (3):415-417 [PubMed]
Vergote I, Amant F, Leunen K, van Gorp T, Berteloot P, Neven P, Metastatic breast cancer: sequencing hormonal therapy and positioning of fulvestrant. INT J GYNECOL CANCER 2006;16 (Suppl. 2):524-526 [PubMed]
Wildiers H, Neven P, Amant F, D'Hooghe T, Paridaens R, Fertility preservation in (breast) cancer patients: is it safe?. J CLIN ONCOL 2006;24 (33):5335-6; author reply 5337-8 [PubMed]
Amant F, Different subtypes of uterine sarcoma require a separate therapeutic approach. WOMENS HEALTH (LOND ENGL) 2005;1 (3):375-383 [PubMed]
Amant F, The rationale for comprehensive surgical staging in endometrial carcinosarcoma. GYNECOL ONCOL 2005;99 (2):521-2; author reply 522-3 [PubMed]
Amant F, Cadron I, Fuso L, Berteloot P, de Jonge E, Jacomen G, van Robaeys J, Neven P, Moerman P, Vergote I, Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer. GYNECOL ONCOL 2005;98 (2):274-280 [PubMed]
Amant F, Moerman P, Neven P, Timmerman D, van Limbergen E, Vergote I, Endometrial cancer. LANCET 2005;366 (9484):491-505 [PubMed]
Amant F, Moerman P, Vergote I, Report of an unusual problematic uterine smooth muscle neoplasm, emphasizing the prognostic importance of coagulative tumor cell necrosis. INT J GYNECOL CANCER 2005;15 (6):1210-1212 [PubMed]
Caluwaerts S, Amant F, Vergote I, Role of cyclin-dependent kinase p27 in uterine carcinosarcomas. INT J GYNECOL CANCER 2005;15 (5):986-7; author reply 988 [PubMed]
de Greef I, Berteloot P, Timmerman D, Deprest J, Amant F, Viable cervical pregnancy with levonorgestrel containing intrauterine device, treated successfully with methotrexate and mifepristone. EUR J OBSTET GYN R B 2005;120 (2):233-235 [PubMed]
Fruscella E, Testa AC, Ferrandina G, de Smet F, van Holsbeke C, Scambia G, Zannoni GF, Ludovisi M, Achten R, Amant F, Vergote I, Timmerman D, Ultrasound features of different histopathological subtypes of borderline ovarian tumors. ULTRASOUND OBST GYN 2005;26 (6):644-650 [PubMed]
Huang HJ, Neven P, Drijkoningen M, Paridaens R, Wildiers H, van Limbergen E, Berteloot P, Amant F, Christiaens MR, Vergote I, Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related. BREAST CANCER RES TR 2005;91 (1):81-87 [PubMed]
Huang HJ, Neven P, Drijkoningen M, Paridaens R, Wildiers H, van Limbergen E, Berteloot P, Amant F, Vergote I, Christiaens MR, Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer. J CLIN PATHOL 2005;58 (6):611-616 [PubMed]
Huang HJ, Neven P, Drijkoningen M, Paridaens R, Wildiers H, van Limbergen E, Berteloot P, Amant F, Vergote I, Christiaens MR, Hormone receptors do not predict the HER2/neu status in all age groups of women with an operable breast cancer. ANN ONCOL 2005;16 (11):1755-1761 [PubMed]
van Calsteren K, Amant F, Vergote I, Role of adnexectomy in the surgical treatment of cervical adenocarcinoma. INT J GYNECOL CANCER 2005;15 (5):984; author reply 985 [PubMed]
van Calsteren K, Vergote I, Amant F, Cervical neoplasia during pregnancy: diagnosis, management and prognosis. BEST PRACT RES CL OB 2005;19 (4):611-630 [PubMed]
Vandenberghe G, Claerhout F, Amant F, Lymphoblastic lymphoma presenting as bilateral gigantomastia in pregnancy. INT J GYNECOL OBSTET 2005;91 (3):252-253 [PubMed]
Vandenput I, Amant F, Vergote I, Peritoneal recurrences might be less common in advanced stage serous borderline ovarian tumors that were treated by laparotomy. GYNECOL ONCOL 2005;98 (3):523; author reply 524-523; author reply 525 [PubMed]
van Mieghem T, Abeler VM, Moerman P, Verbist L, Vergote I, Amant F, CD10, estrogen and progesterone receptor expression in ovarian adenosarcoma. GYNECOL ONCOL 2005;99 (2):493-496 [PubMed]
Vergote I, Marquette S, Amant F, Berteloot P, Neven P, Port-site metastases after open laparoscopy: a study in 173 patients with advanced ovarian carcinoma. INT J GYNECOL CANCER 2005;15 (5):776-779 [PubMed]
Vergote I, van Gorp T, Amant F, Neven P, Berteloot P, Neoadjuvant chemotherapy for ovarian cancer. ONCOLOGY-NY 2005;19 (12):1615-22; discussion 1623-30 [PubMed]
Amant F, Dorfling CM, de Brabanter J, Vandewalle J, Vergote I, Lindeque BG, van Rensburg EJ, A possible role of the cytochrome P450c17alpha gene (CYP17) polymorphism in the pathobiology of uterine leiomyomas from black South African women: a pilot study. ACTA OBSTET GYN SCAN 2004;83 (3):234-239 [PubMed]
Amant F, Schurmans K, Steenkiste E, Verbist L, Abeler VM, Tulunay G, de Jonge E, Massuger L, Moerman P, Vergote I, Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma. GYNECOL ONCOL 2004;93 (3):680-685 [PubMed]
Amant F, Steenkiste E, Schurmans K, Verbist L, Abeler VM, Tulunay G, de Jonge E, Massuger L, Moerman P, Vergote I, Immunohistochemical expression of CD10 antigen in uterine adenosarcoma. INT J GYNECOL CANCER 2004;14 (6):1118-1121 [PubMed]
Amant F, Vergote I, Importance of the endometrioid carcinoma subtype and sarcomatous component in uterine carcinosarcoma. GYNECOL ONCOL 2004;93 (1):272-3; author reply 273-4 [PubMed]
Amant F, Vergote I, Moerman P, The classification of a uterine sarcoma as 'high-grade endometrial stromal sarcoma' should be abandoned. GYNECOL ONCOL 2004;95 (2):412-3; author reply 413 [PubMed]
Amant F, Vloeberghs V, Woestenborghs H, Debiec-Rychter M, Verbist L, Moerman P, Vergote I, ERBB-2 gene overexpression and amplification in uterine sarcomas. GYNECOL ONCOL 2004;95 (3):583-587 [PubMed]
van Gorp T, Amant F, Neven P, Vergote I, Moerman P, Endometriosis and the development of malignant tumours of the pelvis. A review of literature. BEST PRACT RES CL OB 2004;18 (2):349-371 [PubMed]
Vergote IB, Amant F, Early ovarian cancer--time for a rethink on stage?. GYNECOL ONCOL 2004;94 (2):607; author reply 607-607; author reply 608 [PubMed]
Amant F, Gabriel C, Moerman P, Vergote I, Immunohistochemical determination of hormone receptors in uterine adenosarcomas. GYNECOL ONCOL 2003;88 (3):463-464 [PubMed]
Amant F, Huys E, Geurts-Moespot A, Lindeque BG, Vergote I, Sweep F, Schoenmakers EFPM, Ethnic variations in uterine leiomyoma biology are not caused by differences in myometrial estrogen receptor alpha levels. J SOC GYNECOL INVEST 2003;10 (2):105-109 [PubMed]
Amant F, Lottering ML, Joubert A, Thaver V, Vergote I, Lindeque BG, 2-methoxyestradiol strongly inhibits human uterine sarcomatous cell growth. GYNECOL ONCOL 2003;91 (2):299-308 [PubMed]
Amant F, Moerman P, Cadron I, Hagemeijer A, Vergote I, Debiec-Rychter M, Endometrial stromal sarcoma with a sole t(X;17) chromosome change: report of a case and review of the literature. GYNECOL ONCOL 2003;88 (3):459-462 [PubMed]
Amant F, Moerman P, Cadron I, Neven P, Berteloot P, Vergote I, The diagnostic problem of endometrial stromal sarcoma: report on six cases. GYNECOL ONCOL 2003;90 (1):37-43 [PubMed]
Amant F, Vergote I, Bifunctional pathway of uterine carcinosarcomas. HUM PATHOL 2003;34 (3):299; author reply 300 [PubMed]
Amant F, Vloeberghs V, Woestenborghs H, Moerman P, Vergote I, Transition of epithelial toward mesenchymal differentiation during ovarian carcinosarcoma tumorigenesis. GYNECOL ONCOL 2003;90 (2):372-377 [PubMed]
D'Agostino G, Amant F, Berteloot P, Scambia G, Vergote I, Phase II study of gemcitabine in recurrent platinum-and paclitaxel-resistant ovarian cancer. GYNECOL ONCOL 2003;88 (3):266-269 [PubMed]
Gaarenstroom KN, Kenter GG, Trimbos JB, Agous I, Amant F, Peters AAW, Vergote I, Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. INT J GYNECOL CANCER 2003;13 (4):522-527 [PubMed]
Leunen K, Amant F, Debiec-Rychter M, Croes R, Hagemeijer A, Schoenmakers EFPM, Vergote I, Endometrial stromal sarcoma presenting as postpartum haemorrhage: report of a case with a sole t(10;17)(q22;p13) translocation. GYNECOL ONCOL 2003;91 (1):265-271 [PubMed]
Amant F, de la Rey M, Dorfling CM, van der Walt L, Dreyer G, Dreyer L, Vergote I, Lindeque BG, van Rensburg EJ, PTEN mutations in uterine sarcomas. GYNECOL ONCOL 2002;85 (1):165-169 [PubMed]
Amant F, Vergote I, PTEN mutation analysis in uterine leiomyosarcomas and mixed mullerian sarcomas. AM J OBSTET GYNECOL 2002;187 (1):258 [PubMed]
Vergote I, Amant F, Berteloot P, van Gramberen M, Laparoscopic lower para-aortic staging lymphadenectomy in stage IB2, II, and III cervical cancer. INT J GYNECOL CANCER 2002;12 (1):22-26 [PubMed]
Vergote I, de Smet I, Amant F, Incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy. GYNECOL ONCOL 2002;84 (3):537-538 [PubMed]
Amant F, The misoprostal third stage study: a randomised controlled comparison between orally administered misoprostol and standard management. A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stage labour. BJOG-INT J OBSTET GY 2001;108 (3):338 [PubMed]
Amant F, Debiec-Rychter M, Schoenmakers EF, Hagemeijer-Hausman A, Vergote I, Cumulative dosage effect of a RAD51L1/HMGA2 fusion and RAD51L1 loss in a case of pseudo-Meigs' syndrome. GENE CHROMOSOME CANC 2001;32 (4):324-329 [PubMed]
Amant F, Dorfling CM, Dreyer L, Vergote I, Lindeque BG, van Rensburg EJ, Microsatellite instability in uterine sarcomas. INT J GYNECOL CANCER 2001;11 (3):218-223 [PubMed]
Amant F, Dreyer L, Makin J, Vergote I, Lindeque BG, Uterine sarcomas in South African black women: a clinicopathologic study with ethnic considerations. EUR J GYNAECOL ONCOL 2001;22 (3):194-200 [PubMed]
Amant F, Gabriel C, Timmerman D, Vergote I, Pseudo-Meigs' syndrome caused by a hydropic degenerating uterine leiomyoma with elevated CA 125. GYNECOL ONCOL 2001;83 (1):153-157 [PubMed]
Amant F, Moerman P, Davel GH, de Vos R, Vergote I, Lindeque BG, de Jonge E, Uterine carcinosarcoma with melanocytic differentiation. INT J GYNECOL PATHOL 2001;20 (2):186-190 [PubMed]
Amant F, Spitz B, Timmerman D, Corremans A, van Assche FA, Misoprostol compared with methylergometrine for the prevention of postpartum haemorrhage: a double-blind randomised trial. BR J OBSTET GYNAECOL 1999;106 (10):1066-1070 [PubMed]
de Jonge ETM, Viljoen E, Lindeque BG, Amant F, Nesland JM, Holm R, The prognostic significance of p53, mdm2, c-erbB-2, cathepsin D, and thrombocytosis in stage IB cervical cancer treated by primary radical hysterectomy. INT J GYNECOL CANCER 1999;9 (3):198-205 [PubMed]
Timmerman D, Schwärzler P, Collins WP, Claerhout F, Coenen M, Amant F, Vergote I, Bourne TH, Subjective assessment of adnexal masses with the use of ultrasonography: an analysis of interobserver variability and experience. ULTRASOUND OBST GYN 1999;13 (1):11-16 [PubMed]
Amant F, Berteloot P, Vergote I, Gastrostomy using a "Gastrofix" as an alternative for nasogastric tubes in ovarian cancer surgery. GYNECOL ONCOL 1998;71 (3):348-351 [PubMed]
Amant F, Spitz B, Arnout J, van Assche FA, Hepatic necrosis and haemorrhage in pregnant patients with antiphospholipid antibodies. LUPUS 1997;6 (6):552-555 [PubMed]
van Hoe L, Gryspeerdt S, Amant F, Marchal G, Baert AL, Spitz B, Abdominal pain in the postpartum: role of imaging. J BELGE RADIOL 1995;78 (3):186-189 [PubMed]
Missiaen L, Wuytack F, de Smedt H, Amant F, Casteels R, AIF4-induced inhibition of the ATPase activity, the Ca2+-transport activity and the phosphoprotein-intermediate formation of plasma-membrane and endo(sarco)plasmic-reticulum Ca2+-transport ATPases in different tissues. Evidence for a tissue-dependent functional difference. BIOCHEM J 1989;261 (2):655-660 [PubMed]
Key publications

Amant F, Vandenbroucke T, Verheecke M, Fumagalli M, Halaska MJ, Boere I, Han S, Gziri MM, Peccatori F, Rob L, Lok C, Witteveen P, Voigt JU, Naulaers G, Vallaeys L, van den Heuvel F, Lagae L, Mertens L, Claes L, van Calsteren K, Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy. NEW ENGL J MED 2015;373 (19):1824-1834 [PubMed]
Amant F, Loibl S, Neven P, van Calsteren K, Breast cancer in pregnancy. LANCET 2012;379 (9815):570-579 [PubMed]
Amant F, van Calsteren K, Halaska MJ, Gziri MM, Hui W, Lagae L, Willemsen MA, Kapusta L, van Calster B, Wouters H, Heyns L, Han SN, Tomek V, Mertens L, Ottevanger PB, Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. LANCET ONCOL 2012;13 (3):256-264 [PubMed]
Amant F, von Minckwitz G, Han SN, Bontenbal M, Ring AE, Giermek J, Wildiers H, Fehm T, Linn SC, Schlehe B, Neven P, Westenend PJ, Müller V, van Calsteren K, Rack B, Nekljudova V, Harbeck N, Untch M, Witteveen PO, Schwedler K, Thomssen C, van Calster B, Loibl S, Prognosis of Women With Primary Breast Cancer Diagnosed During Pregnancy: Results From an International Collaborative Study. J CLIN ONCOL 2013;31 (20):2532-+ [PubMed]
Amant F, van den Bosch T, Vergote I, Timmerman D, Morcellation of uterine leiomyomas: a plea for patient triage. LANCET ONCOL 2015;16 (15):1454-1456 [PubMed]


All Publications

Research programmes

Cancer In Pregnancy - Translational Research & Immunotherapy - Patient Derived Tumor Xenografts

Faculty
Prof. dr. F.C.H. Amant MD PhD (Center Gynaecologic Oncology Amsterdam (AMC, NKI-AVL))

Postdocs
D. Annibali (KU Leuven & NKI)
L. Lenaerts (KU Leuven)
S. Tuyaerts (KU Leuven)

PhD Students
J. Blommaert (KU Leuven)
S. Conings (KU Leuven)
T.C. Cuppens (KU Leuven)
J. Depreeuw (KU Leuven)
Dr. J. de Haan (VU & KU Leuven)
E. Hermans DVM (KU Leuven)
H. Lefrère (KU Leuven)
S. Moens (KU Leuven)
T. Van Nyen (KU Leuven)
J. Stans (KU Leuven)
T. Vandenbroucke (KU Leuven)
Dr. M. Verheecke (KU Leuven)

Prof. dr. G.G. Kenter MD PhD (gynaecologic Oncology)

Other research related activities
  • None reported
Current research funding
  • AMC (Vrijgesteld)